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ABSTRACT
Biological and biomedical measurements, when adequately analyzed and pro-
cessed, can be used to impart quantitative diagnosis during primary health care con-
sultation to improve patient adherence to recommended treatments. For example,
analyzing neural recordings from neurostimulators implanted in patients with neuro-
logical disorders can be used by a physician to adjust detrimental stimulation parame-
ters to improve treatment. As another example, biosequences, such as sequences from
peptide microarrays obtained from a biological sample, can potentially provide pre-
symptomatic diagnosis for infectious diseases when processed to associate antibodies
to specific pathogens or infectious agents. This work proposes advanced statistical
signal processing and machine learning methodologies to assess neurostimulation from
neural recordings and to extract diagnostic information from biosequences.
For locating specific cognitive and behavioral information in different regions of
the brain, neural recordings are processed using sequential Bayesian filtering methods
to detect and estimate both the number of neural sources and their corresponding
parameters. Time-frequency based feature selection algorithms are combined with
adaptive machine learning approaches to suppress physiological and non-physiological
artifacts present in neural recordings. Adaptive processing and unsupervised cluster-
ing methods applied to neural recordings are also used to suppress neurostimulation
artifacts and classify between various behavior tasks to assess the level of neurostim-
ulation in patients.
For pathogen detection and identification, random peptide sequences and their
properties are first uniquely mapped to highly-localized signals and their correspond-
ing parameters in the time-frequency plane. Time-frequency signal processing meth-
ods are then applied to estimate antigenic determinants or epitope candidates for
detecting and identifying potential pathogens.
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Chapter 1
INTRODUCTION
1.1 Neural Activity Processing
1.1.1 Neural Source Estimation and Challenges
Illnesses of the mind have historically been misunderstood. We are only recently
starting to make real progress on understanding the mechanisms and treatment of
these diseases. Historically, from trepanation to asylums to the misuse of electroshock
therapy, it has been a troubling path towards the modern day in working with the
brain [5]. Even with an illness of the brain that shows effects primarily in the body
like Parkinson’s disease, the functional early treatments had significant risk and were
fairly drastic, involving scarring areas of the brain to restore a degree of function [6, 7].
Thanks to new technology, we have been able to make progress since the early 1900s
in understanding neurons and how behaviors arise [8–10]. Mapping the brain has
been declared one of the “Grand Challenges of the Mind and Brain” by the National
Science Foundation, and it is also a “Grand Challenge” according to the National
Academy of Engineering [8]. Computing power keeps improving, and many new
techniques and technologies can help to solve the problem of mapping the brain [11].
Parkinson’s disease treatment has advanced through medications up to deep brain
stimulation, which is a focus of this research, along with neural activity localization.
The various scans and measurement techniques available have trade offs, often
between time resolution and space resolution [11]. Methods that look at blood flow
around neurons, like positron emission tomography (PET), magnetic resonance imag-
ing (MRI), and transcranial optics, have strong spacial resolution but poor time res-
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olution. This is because the blood flow, which is the measure of activity for these
methods, is a somewhat slow process. On the other hand, methods such as electroen-
cephalograms (EEG) and magnetoencephalograms (MEG) have strong time resolu-
tion, as electromagnetic information changes quickly, but poor spacial resolution,
since the fields around the entire head are affected by local activity [11–13].
The process of mapping the brain has already lead to advances in the understand-
ing of brain function. The University of Chicago has worked on localizing seizure ac-
tivity. They found that the orientation of the sources differentiated between seizures
from different parts of the temporal cortex [14, 15]. Localized sources are good fea-
tures to use in brain-machine interfaces (BMI), which, as their name implies, allow
a level of communication between the brain and machines. This is useful for ap-
plications like virtual reality, synthetic limbs, and other machines interacting with
the mind [16]. Researchers have examined source localizations in a variety of mental
states, including depression compared to alcoholism [17] and anxiety versus relax-
ation [18]. Diseases of the brain are challenging to treat, and brain mapping is a
great step toward being able to improve and discover treatments [11]. Mental dis-
orders are actually fairly common, and 26.2% of American adults experience mental
disorders every year [19]. Mental illnesses are the third most common disability, after
hearing and vision problems. [20].
One of the goals of this work is to improve the spacial resolution of EEG by local-
izing the activity in the brain. This can be done by solving the inverse problem, going
from measurements to neural sources. The source model we use is a localized dipole
of current with a particular position and orientation. It is intended to approximate
the action potential of neurons [2, 11, 21–23]. Many neurons working together form
a localized current, resulting in volume currents and the propagation of electromag-
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netic fields through the head, which can be measured with sensors. MEG measures
the magnetic field and EEG measures the electric potential.
Different methods have been used to solve the inverse problem in literature [4, 11,
13, 24–37], including recursively applied projected multiple signal classification (RAP
MUSIC) [13, 24], spatial filtering or beamforming [25], low resolution electromagnetic
tomography (LORETA), and Bayesian methods, such as Kalman filtering in [28,
31] and particle filtering in [26, 29, 31]. Methods using the probability hypothesis
density filter (PHDF) were considered in [36, 37] to estimate both the unknown
number of neural dipole sources and their parameters for real EEG/MEG data, and
the probabilistic data association filter was applied in [4].
Artifact signals, which are signals that show up in measurements of the brain,
but do not originate from the brain, are important to account for [38–48]. They
include physiologic artifacts like muscle movements, breathing and heartbeat, and
non-physiologic artifacts like the signal leaking from the power line, electrode pop-
ping, sweat on the electrode, or movement of the patient. Artifacts corrupt the
measurements of EEG and MEG, impeding analysis. Thus, various methods were
used for artifact suppression including independent component analysis (ICA) fol-
lowed by pattern recognition [39, 49], wavelets [45], regression techniques [41], and
using principle component analysis along with minimum norm estimation [40]. Noise
canceling filters were used in real time in [47, 48] and blind source separation in [46].
1.1.2 Neurostimulation
An important applicability of realizing relations between function and brain region
is to assist in the therapy and monitoring of subjects with implantable neurostimula-
tors. Neurostimulation is a neurosurgical procedure that modifies the brains electrical
activity to provide potential treatments for a large spectrum of neurological disor-
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ders, such as Parkinson’s disease, essential tremor, and most recently, depression and
obsessive-compulsive disorder [50]. Neurostimulation modulates local field potential
(LFP) oscillations in the deep brain nuclei and affects cortical and subcortical con-
nections, key to decision-making, learning and cognitive association [51, 52]. The
complexity of these networks and the placement of the neurostimulation results in a
variety of individual specific effects in behavior and cognitive function. These are also
dynamic networks, which cause side effects to vary over time. To advance neurostim-
ulation and reduce its side effects, it is crucial to understand inter-subject variability
from the neural signals. However, there currently does not exist a method to measure
the impact of neurostimulation on cognitive functionality.
Parkinson’s disease is a degenerative age-related brain disorder caused by the
death of neurons responsible for contributing to dopamine production, resulting in
tremors and muscle control difficulties. While there are effective medications for
managing the symptoms, deep brain stimulation (DBS) is an option in certain cases,
including when medications have significant side effects for a certain patient [6, 7,
53, 54]. DBS is a reversible surgical technique that uses implanted electrodes. It has
replaced permanent techniques, surgeries called pallidotomies and thalamotomies,
that remove small areas of the brain [7, 55]. The electrodes are used to apply an
electrical waveform deep into the brain, similar to a pacemaker for the heart [6, 53,
54, 56]. An important research direction is detecting when the parameters of the
stimulation waveform need to change to improve the efficacy of the treatment.
EEG as well as other measurements can be used to monitor brain activity in
Parkinson’s disease patients, as well as understand what happens in the brain when
patients perform activities that can aggravate Parkinson’s disease symptoms. We
would like to use this monitoring to adjust the DBS parameters and improve the
quality of disorder treatment. This will be achieved by using EEG to detect when the
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stimulation parameters need adjustment due to changes in the symptoms of Parkin-
son’s disease, to improve upon the current open loop DBS system. Our work toward
this end is to classify segments of EEG of patients performing different tasks without
DBS, as well as using specific filter methods to remove the DBS artifact and classify
the tasks even when the DBS is active. Differences in the beta and gamma bands
of neural activity can be seen in Parkinson’s disease patients, and can be measured
with EEG and used for classification of patient activity. The classification can be
used for monitoring how the DBS treatment is working and if adjustments need to
be made [16, 28, 57–67].
When drug therapy is no longer sufficient, DBS can alleviate motor symptoms
by targeting the subthalamicnucleus (STN) using high-frequency electrical stimula-
tion [6, 53, 54, 56]. Similar to the majority of neurostimulation systems, clinicians are
able to use one or a configuration of multiple electrodes to apply electrical stimulation
to a small target area. Efficacy of DBS relies on the accuracy of placement of the
DBS lead at the target area, which is typically on the order of 5 mm in diameter.
DBS leads are inserted into the target area with the guidance of a stereotactic frame
while patients are awake, allowing neurophysiological recording of brain areas and
intraoperative monitoring of electrical stimulation side effects and clinical efficacy.
Note, however, that DBS also has negative side effects in certain people such as im-
pairments in cognitive function [54, 68]. Studies have also demonstrated that DBS
impairs verbal fluency [69–72] and reactive inhibition [73, 74].
Current methods for removing DBS artifact in EEG include local curve fitting [75,
76], empirical mode decomposition (EMD) detrending followed by time-frequency
filtering [77], undersampling and interpolation [78], Hampel filtering [79], and matched
filtering [80].
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1.2 Proposed Work for Artifact Suppression in Source Estimation and
Neurostimulation
Our approach to localizing neural activity while suppressing artifacts is the use of
a particle filter implementation of the probabilistic data association filter (PDAF) [3,
4, 81–84]. The PDAF is designed to take in measurements of uncertain origin, which
include source measurements and artifact measurements, where the sources and ar-
tifacts have different distributions and average densities in the measurement space.
It requires the number of sources to be known a priori, accounting for all possible
association possibilities between measurements and sources [3, 4, 81–84]. We propose
the use of the PDAF to suppress artifact activity, such as eye blinks and movements,
while tracking neural activity. We integrate the PDAF with ICA that is used to
obtain separated measurements that lack association to sources, requiring a method
such as the PDAF to determine which measurements belong to artifacts or sources
and which source the measurement is associated with. The measurements are not
preprocessed after ICA other than performing a transformation of the data to al-
low the PDAF to discriminate between the source model and artifact model, unlike
methods that require preprocessing to reject measurements before tracking.
We also look at the probability hypothesis density filter (PHDF) [22, 23, 36, 37, 85–
89] to track an unknown number of sources. It can be used to estimate the number of
sources present as well as the parameter values for the sources by propagating the first
moment of the source random finite set, the probability hypothesis density (PHD).
The PHD has the property that when integrated over any region of the measurement
space, it provides the expected number of sources in the region. The peaks of the
PHD are where the sources are most likely to be [23, 37, 85].
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We consider various methods to suppress DBS artifacts that can impede task pro-
cessing and classification, including matched filters [80], Hampel filters [79], and the
empirical mode decomposition [90–92]. We then concentrate on the beta and gamma
frequency bands that DBS has been shown to affect [16, 28, 57–67], using the DBS
artifact suppressed EEG in an adaptive learning clustering method to discriminate
between behavioral tasks in Parkinson’s disease patients implanted with neurostimu-
lators. The ultimate goal is to find a biomarker for the Parkinson’s disease treatment,
in order to perform home monitoring using EEG. We perform classification using
Gaussian mixture modeling (GMM) [93]. The advantage to this classifier is that the
Dirichlet process Gaussian mixture model (DP-GMM) [94–102] does not need the
number of tasks specified beforehand. It can also be used to adaptively classify the
tasks when new EEG data becomes available. If the new data is classified as belong-
ing to the same task, then it can be deduced that no changes have occurred with the
patient’s condition. If new classes are formed, then that could indicate that the DBS
parameters need to be adjusted.
1.3 Thesis Organization
The rest of the thesis is organized as follows. In Chapter 2, we present the par-
ticle filter implementations of the PDAF and PHDF. In Chapter 3, we present the
non-linear EEG model for neural sources, as well as a model for signals arising from
artifacts. After proposing a transformation of the observed measurements to bet-
ter separate sources from artifacts, we tie these models into the PDAF and PHDF
equations to show how artifacts can be suppressed. We then present results showing
artifact suppression while tracking neural sources. In Chapter 4, we further discuss
Parkinson’s disease and deep brain stimulation, then present the GMM and DP-GMM
for classification using features from the matching pursuit decomposition. We show
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results from using the DP-GMM to classify local field potential measurements from
different tasks. In Chapter 5, we discuss the artifact signal that is created by the
operation of the DBS unit, as well as methods to remove this artifact, including the
Hampel filter, EMD, and sinusoidal matched filter. Finally, we present results show-
ing the classification of EEG measurements for different taasks in Parkinson’s patients
with the DBS unit active and inactive. Chapter 6 contains conclusions and future
work. Appendix A presents a previously published book chapter on work completed
during this Ph.D., that is unrelated to the neural activity work in the main chapters.
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Chapter 2
SEQUENTIAL BAYESIAN FILTERING METHODS FOR DYNAMIC
PARAMETER ESTIMATION
2.1 The Particle Filter Algorithm
The particle filter (PF) is a technique used with non-linear, dynamic system mod-
els and non-Gaussian noise situations to estimate unknown time-varying parameters
in noisy conditions. It uses measurements that are taken over time of a system whose
underlying parameters are changing over time. The measurements or processed in-
formation received are not directly related to the unknown parameters of interest.
The particle filter algorithm uses a system representation in terms of two models:
a model that maps the noisy measurements into the parameter space to the mea-
surement space, and a transition model that relates the current and past parameter
values. When the models are linear and the measurement noise is Gaussian, the
Kalman filter [103] can be employed, which performs the estimation in closed form.
For non-linear models and non-Gaussian noise, the particle filter can be used instead
of the Kalman filter. A common problem solved with Kalman or particle filters is
the tracking of the positions and velocities of targets in a radar system. Another
problem is the estimation of the location and orientation of neural activity given
EEG/MEG recordings from sensors placed at various points on the head to measure
electromagnetic fields. Using acceptable models that relate the physical unknown
parameters, estimates of neural activity should give information about the status of
a patient [104, 105].
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We consider the general problem of estimating the dynamic state parameter vector
xk of a moving object using the noisy measurement vector zk at time step k. The state
space model has two equations, describing how the underlying parameters change
over time and how the measurement is related to the underlying parameters. These
equations are: [105].
xk = fk(xk−1) + uk−1. (2.1)
zk = hk(xk) + vk. (2.2)
In (2.1), fk(xk−1) is the transition function of the parameters at time k− 1, and uk−1
is a random process vector that represents possible errors in the function. Specifically,
the function describes how the state at time k−1 transitions to the new state at time
k, and the random process vector includes both the random portions of the model
transitions and any error in the transition model. In (2.2), zk is the measurement
vector obtained from the system, and hk(xk) is the measurement function that relates
the state parameter vector, xk, to the measurement vector, zk. The measurement
noise vector vk can include both the noise that comes from taking the measurement
as well as any error in the measurement model [84, 105].
If fk(·) and hk(·) are linear and uk and vk are Gaussian, xk can be estimated in
closed form using the Kalman filter [104]. The extended Kalman filter [106] and the
unscented Kalman filter [107] can be used for non-linear functions; however, when
fk(·) and hk(·) are non-linear and uk−1 and vk are non-Gaussian, the particle filter is
a popular choice to find a sequential Monte Carlo estimate of the state parameters.
[105].
The particle filter arises from taking a state model and measurement model for
a system and looking to estimate the state from measurements taken of the system.
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The goal is to obtain an estimate,xˆk of the system state, xˆk at time step k, given a set
of measurements, Z1:k = {z1, z2, . . . zk}, up to time k. The minimum mean-squared
error (MMSE) estimator of xk can be given by
xˆk = E[p(xk|Z1:k)], (2.3)
where E[·] denotes statistical expectation and p(xk|Z1:k) is the posterior distribution
of the state. This estimator simply minimizes the error of the estimate by using
the posterior distribution. In practice the posterior distribution is not available.
The particle filter approximates the posterior distribution as a discrete distribution
of samples or “particles.” Particles in the state space form a discrete probability
distribution as long as each particle has a weight, and the weights sum to one. With
enough particles and a good way of finding weights, we can approximate the posterior
distribution, p(xk|Z1:k).
There are two steps to implementing the particle filter algorithm: a state and par-
ticle update called the prediction step, and a weight update called the update step,
which arises naturally from a few rules of conditional probability. The prediction
step uses Equation (2.1) to predict the new state from the old state. This is done
by updating each particle’s location in the state space. The update step uses Equa-
tion (2.2) to update the weights for each particle. The process begins by drawing
an initial set of particles in the state space from a distribution p(x0). These steps
alternate to estimate the state of the system at each time step, with one iteration of
prediction and update per time step.
The prediction step uses the Chapman-Kolmogorov equation to account for the
past state possibilities:
p(xk|Z1:k−1) =
∫ ∞
−∞
p(xk|xk−1)p(xk−1|Z1:k−1)dxk−1. (2.4)
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In this equation, the newest measurement, zk, has not been used yet. The predic-
tion step can be completed using the estimated posterior from the last update step,
p(xk−1|Z1:k−1), and the transition probability density function (pdf), p(xk|xk−1), that
arises from the state equation, Equation (2.1). Bayes’ rule can then be used to com-
plete the update step, and obtain the posterior density as
p(xk|Z1:k) = p(zk|xk)p(xk|Z1:k−1)∫∞
−∞ p(zk|xk)p(xk|Z1:k−1)
. (2.5)
The integrals in (2.4) and (2.5) cannot be evaluated in closed form. Instead, let
x
(n)
k and w
(n)
k , n = 1, . . . , N denote a set of N particles and associated weights. Then
we obtain the approximate posterior:
p(xk|Z1:k) ≈
N∑
n=1
w
(n)
k δ
(
xk − x(n)k
)
. (2.6)
More particles will yield a better estimate of the posterior pdf and thus a better
estimate of the parameters xk. The state estimate can be found as above in (2.6) as
xˆk =
∫
xkp(xk|Z1:k)dxk ≈
N∑
n=1
w
(n)
k x
(n)
k . (2.7)
We use the sampling importance resampling particle filter (SIR PF) algorithm,
since we cannot sample from the posterior pdf. This method uses an importance
density q(xk|Z1:k) to sample from, which is ideally as close to the posterior as possible,
but easily samplable [105]. It is not the true distribution, so we modify the samples
we get from it. If q(xk|Z1:k) = p(xk|Z1:k), then we do not need to weight the samples
to obtain samples from p(·|Z1:k), as we are sampling from the true posterior. However,
q(xk|Z1:k) 6= p(xk|Z1:k), so we need to weigh our samples. The weighted distribution
can be written as:
w
(n)
k ∝
p(x
(n)
k |Z1:k)
q(x
(n)
k |Z1:k)
, (2.8)
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where the weights sum to 1 over all n, in order to form a valid pdf. A powerful class
of proposal distributions have the following property:
q(xk|Z1:k) = q(xk|xk−1, zk) q(xk−1|Z1:k−1). Then x(n)k can be sampled from
q(xk|xk−1, zk). It can then be shown using Bayes’ rule and the Chapman-Kolmogorov
equation that (2.8) can be factored to obtain
w
(n)
k ∝
p(zk|x(n)k )p(x(n)k |x(n)k−1)p(x(n)k−1|Z1:k−1)
q(xk|xk−1, zk)q(xk−1|Z1:k−1) . (2.9)
Then (2.8) and (2.9) give the result that
w
(n)
k ∝ w(n)k−1
p(zk|x(n)k )p(x(n)k |x(n)k−1)
q(xk|xk−1, zk) . (2.10)
A simple choice for a known distribution with this property is the distribution derived
from the state update equation, Equation (2.1). This results in the prediction of
xk only depending on xk−1. The proposal distribution is then, q(xk|Xk−1,Zk) =
p(xk|xk−1). This causes (2.10) to reduce to
w
(n)
k ∝ w(n)k−1p(zk|x(n)k ). (2.11)
Particle x
(n)
k is obtained from x
(n)
k−1 via (2.1), as this is a draw from p(xk|xk−1).
The associated weight is updated to w
(n)
k from w
(n)
k−1 via (2.2), which is a draw from
p(zk|x(n)k ).
A situation called “particle degeneracy” is a common problem for the particle
filter. As the particle filter operates, individual particles obtain high weights and the
other particles vanish. Resampling the particles can be used to avoid this issue. This
is done between time steps after obtaining the final estimate for the time step. Low
weight particles are thrown away and high weight particles are split into multiple
lower weight particles at the same location in the state space. There are several
different ways to employ resampling. A commonly used approach first finds the
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cumulative distribution for the posterior distribution by numbering the particles with
the integers. For the nth pre-resampling particle, we denote the cumulative sum of
the weights as cn, for n = 1, . . . , N , with N being the number of particles. We then
draw a threshold, d0 from a uniform distribution on [0, 1/N), and we calculate the
next threshold, dm = d0 + (m − 1)/N , for m = 1, . . . , N . While cn ≥ dm, the mth
resampled particle is set equal to the nth pre-resampling particle, with weight 1
N
;
then once cn < dm, we compare the cumulative weight of the next particle to the
threshold [105]. This generates N new particles with weight 1
N
, a valid pdf estimate.
The overall particle filter algorithm presented so far is for the theoretical case of
estimating the parameters of a single object, and it is summarized in Algorithm 1 [3,
23, 105]. It can be extended to multiple objects given a known measurement associa-
tion, so that we know which object generated which measurement. However, such an
association is not normally available. If the measurement sources are independent,
we can use a separate particle filter for each source.
2.2 Probabilistic Data Association Filter
The particle filter on its own is able to track a fixed and known number of ob-
jects when the association of measurement to object is known. When the association
of measurement to source is not known, the particle filter can be modified to im-
plement the probabilistic data association filter, which accounts for all association
possibilities [3, 4, 81–84].
The PDAF assumes imperfect source detection, with probability of detection PDk .
It also assumes that spurious measurements also appear, called clutter. Clutter is
modeled as arising from a point Poisson process, which is distributed in the measure-
ments space according to some probability distribution. In the PDAF, the distribution
is uniform. The average number of clutter measurements at a given time is λ, though
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Algorithm 1 SIR Particle Filter Algorithm.
Initialization
. Sample N particles x
(n)
0 ∼ p(x0) {chosen uniform over expected state values}
. Compute associate weights w
(n)
0 = 1/N , n = 1, . . . , N
while k ≤ K do
Prediction Stage {K is the maximum time step}
. Predict the state for each particle according to x
(n)
k = x
(n)
k−1 + u
(n)
k−1
. Maintain the weights w
(n)
k−1 = w
(n)
k−1
Update Stage
. Maintain particle x
(n)
k
. Update corresponding weight w
(n)
k = w
(n)
k−1 p(zk|x(n)k )
. Normalize the particle weights to sum up to 1
Resampling Stage
. Evaluate the cumulative sampled distribution cn
. Draw threshold d0 from a uniform distribution between 0 and 1/N
. Initialize m = 1 and n = 1
for m = 1 : N do
dm = d0 + (m− 1)/N
if cn ≥ dm then
Replicate the particle
x
(m)
k,resamped = x
(n)
k
w
(m)
k,resamped = 1/N
else
Discard the particle
Set n = n+ 1
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end if
end for
. x
(m)
k = x
(m)
k,resamped, m = 1, ..., N
. w
(m)
k = w
(m)
k,resamped, m = 1, ..., N
. Set k = k + 1
end while
the number is Poisson distributed. The PDAF assumes the distribution of the clutter
measurements over the measurement space is uniform, resulting in a clutter density
of %, and also assumes a validation region in the measurement space around the ex-
pected object locations, of volume Vk. So, the probability of ζk clutter measurements
arising at at time k is given by [81–84]:
ψ(ζk) =
exp(−% Vk)(% Vk)ζk
(ζk)!
, (2.12)
Since the PDAF has clutter measurements and may have missed detections, we obtain
mk ≥ 0 measurement components at time k, Zk = {zk,1zk,2 . . . zk,mk}. This includes
measurements from objects and clutter, but we cannot be sure how many are from
the known number of objects. If we assume that all different possible associations for
a given number of detections are independent and equally likely, then we can combine
their likelihoods. If the objects are well separated in the measurement space, their
validation regions do not overlap, and the objects are tracked independently. For the
lth object, we have [81–84]:
p(Zk|xk,l) ∝ (1− Pdk)ψ(mk)V −mkk +
Pdkψ(mk − 1)V −(mk−1)k
mk
mk∑
j=1
p(zk,j|xk,l) .
which simplifies to
p(Zk|x(n)k,l ) ∝ (1− Pdk) +
Pdk
%
mk∑
j=1
p(zk,j|xk,l) . (2.13)
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For more than one object, at each time step, the objects are tracked jointly if
some measurements fall within the validation regions of more than one object. The
possible associations at time step k can be given by [81]
Bk =
mk⋂
l=1
Bk,j,lj ,
where Bk,j,lj is the event that the jth measurement came from the ljth object and mk
is the number of measurements at time step k. The association probability is [81],
p(Bk|Zk) ∝
∏
j
(
1
%
p(zk,j|xk,lj))τj
∏
l
(Pdk)
δl(1− Pdk)1−δl , (2.14)
where % is the clutter density, zk,j is the jth measurement, xk,lj is the state for object
lj, τj is the jth measurement association indicator, and δl is the lth object detection
indicator.
For the case of two objects, we obtain the joint probability,
p(Zk|xk,1,xk,2) ∝ (1− Pdk)2 (2.15)
+
Pdk(1− Pdk)mk
%n1
∑
i∈J1
p(zk,i|xk,1) + Pdk(1− Pdk)mk
%n2
∑
j∈J2
p(zk,j|xk,2)
+
P 2dkmk(mk − 1)
%n
∑
i∈J1∪J3,j∈J2∪J3,i 6=j
p(zk,i|xk,1)p(zk,j|xk,2) .
in this expression, n = [n1n2 +n1n3 +n2n3 +n3(n3−1)] and J1, J2, and J3 are the sets
of measurement indices that fall within the validation regions of object 1, object 2,
and both objects. Additionally, n1, n2, and n3 are the number of indices in each set.
This can be generally extended to more jointly tracked objects, as discussed in [81–
84]. Marginal distributions can be calculated and used in particle filtering [82, 84].
The data association algorithm is summarized in Algorithm 2.
2.3 Probability Hypothesis Density Filter
While data association is able to handle unknown measurement associations, it re-
quires that the number of objects be known. When this is not the case, the probability
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Algorithm 2 SIR Particle Probabilistic Data Association Algorithm.
Initialization
Given known number of objects L
. Sample N particles for each object x
(n)
0,l ∼ p(x0) {chosen uniform over expected
state values}
. Compute associate weights w
(n)
0,l = 1/N , n = 1, . . . , N
while k ≤ K do
Prediction Stage {K is the maximum time step}
. Predict the state for each particle according to x
(n)
k,l = x
(n)
k−1,l + u
(n)
k−1
. Maintain the weights w
(n)
k−1,l = w
(n)
k−1,l
Update Stage
. Maintain particle x
(n)
k,l
. Perform measurement validation for each object based on its prediction
location at time k − 1
For all objects l that can be tracked independently at time k
. Update corresponding weight w
(n)
k,l = w
(n)
k−1,l p(Zk|x(n)k,l ) (Eq. 2.13)
. Normalize the particle weights to sum up to 1
For all groups of objects l1, l2, ..., l` that must be jointly tracked at time k
. Calculate joint weights w
(n1,...n`)
k,(l1,...,l`)
= (
∏`
i=1
w
(ni)
k−1,li) p(Zk|x
(n1)
k,l1
, ...,x
(n`)
k,l`
) (Eq. 2.14
and 2.15)
. Marginalize out corresponding weights w
(ni)
k,li
. Normalize the particle weights to sum up to 1
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Resampling Stage
. Evaluate the cumulative sampled distribution cn for each object l, one at a
time
. Draw threshold d0 from a uniform distribution between 0 and 1/N
. Initialize m = 1 and n = 1
for m = 1 : N do
dm = d0 + (m− 1)/N
if cn ≥ dm then
Replicate the particle
x
(m)
k,resamped = x
(n)
k
w
(m)
k,resampled = 1/N
else
Discard the particle
Set n = n+ 1
end if
end for
. x
(m)
k,l = x
(m)
k,l,resamped, m = 1, ..., N
. w
(m)
k,l = w
(m)
k,l,resamped, m = 1, ..., N
. Set k = k + 1
end while
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hypothesis density filter (PHDF) can be used to estimate the number of objects, even
when the number varies with time [22, 23, 36, 37, 85–89]. The PHDF uses the idea of
random finite sets (RFS) to handle the varying number of objects to track [85]. The
underlying state has a varying number of objects with corresponding parameter vector
set given by, Xk = {xk,1, ...,xk,Nk}, where Nk is the number of objects at time at each
time step k. There is also varying number of measurements, Zk = {zk,1, ..., zk,Mk}
at time step k, where Mk is the number of measurements at time k. In the PHDF
algorithm, these measurements are not known to be associated to any object, some
objects may fail to generate a measurement, and some measurements may originate
from clutter, instead of an object [85, 87–89]. Measurements from clutter become part
of the RFS and a probability of object detection is included in the PHDF algorithm.
2.3.1 PHDF Formulation
The state RFS Xk and xk ∈ Xk, as well as the measurement RFS Zk, can be char-
acterized using the probability hypothesis density or complexity function, ζ(xk|Zk).
Integrating this function on a region R gives the expected number of objects within
the region. The peaks in the distribution are estimates of the state parameters of the
objects [85–89].
We form a new state RFS Xk from the RFS at the previous time step k, Xk−1.
The new state RFS consists of the states of the objects still present from the previous
time step, represented as Xprevk|k−1, the states of newly appearing objects, represented as
Xnewk , and the state of objects that spawned from objects in the previous time step,
represented as Xspnk|k−1. The PHDF assumes that the prior and posterior densities
for the states of the multiple objects can be characterized by their first moments.
The prior intensity function at time k, ζ(xk|Z1:k−1), can then be obtained from the
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posterior intensity at time step k − 1, ζ(xk−1|Z1:k−1) as,
ζ(xk|Z1:k−1) = ζ(xnewk )
+
∫
[Pk|k−1(x˜k−1)p(xk|x˜k−1) + ζ(xspnk |x˜k−1)]
ζ(x˜k−1|Z1:k−1)dx˜k−1,
(2.16)
where xnewk ∈ Xnewk ,xspnk ∈ Xnewk|k−1, and Pk|k−1(x˜k−1) is the probability of a object
present at time step k − 1 remaining at time step k. Then we can determine the
posterior as,
ζ(xk|Z1:k) = (1− PDk(xk))ζ(xk|Z1:k−1)
+
∑
zk,m∈Zk
PDk(xk)p(zk,m|xk)ζ(xk|Z1:k−1)
ζ(Zcltk ) +
∫
PDk(x˜k)p(zk,m|x˜k)ζ(x˜k|Z1:k−1)dx˜k
,
(2.17)
where PDk(xk) is the detection probability at time step k, and ζ(Z
clt
k ) is the clutter
intensity. In this forumlation, measurements are assumed to be mutually independent
and the clutter and objects also assumed independent.
2.3.2 Implementation of PHDF using PF
The PHDF can be implemented using a particle filter, as shown in a radar context
in [85, 87–89]. The intensity function, ζ(xk−1|Z1:k−1) at time step k − 1 can be
approximated with Np particles and associated weights, x
(`)
k−1,w
(`)
k−1 for ` = 1, ..., Np,
as follows,
ζ(xk−1|Z1:k−1) =
Np∑
`=1
w
(`)
k−1 δ
(
xk − x(n)k
)
. (2.18)
The prediction step can be written as
ζ(xk|Z1:k−1) =
Np∑
`=1
w
(`)
k−1[Pk|k−1(x˜
(`)
k−1)p(xk|x˜(`)k−1) + ζ(xspnk |x˜(`)k−1)] + ζ(xnewk ). (2.19)
We then apply importance sampling as described in Section 2.1 for the particle
filter algorithm. The first Np samples are drawn from qk(x
(`)
k |x(`)k−1,Z1:k−1), and the
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next Nq samples are drawn from an importance intensity function Ek(x
(`)
k |Z1:k−1).
Note thatNp andNq are user-specified. We then obtain a representation with particles
and associated weights, x
(`)
k ,w
(`)
k|k−1 for ` = 1, ..., Np +Nq:
ζ(xk|Z1:k−1) =
Np+Nq∑
`=1
w
(`)
k|k−1δ(xk − x(`)k ), (2.20)
where
w
(`)
k|k−1 =

w
(`)
k−1
[Pk|k−1(x
(`)
k−1)p(x
(`)
k |x
(`)
k−1)]+ζ(x
(`),spn
k |x
(`)
k−1)
qk(x
(`)
k |x
(`)
k−1,Z1:k−1)
, ` = 1, ..., Np
ζ(x
(`),new
k )
Nq Ek(x
(`)
k |Z1:k−1)
, ` = Np + 1, ..., (Np +Nq)
If spawned objects are not allowed by the model, and the proposal distributions are
chosen to be qk(x
(`)
k |x(`)k−1,Z1:k−1) = p(x(`)k |x(`)k−1) and Ek(x(`)k |Z1:k−1) = ζ(xnewk |Z1:k),
then this simplifies to
w
(`)
k|k−1 =

w
(`)
k−1[Pk|k−1(x
(`)
k−1)], ` = 1, ..., Np
ν
Nq
, ` = Np + 1, ..., (Np +Nq),
where ν is the expected number of new objects. We then obtain via substitution the
representation for the posterior intensity,
ζ(xk|Z1:k) =
Np+Nq∑
`=1
w
(`)
k δ(xk − x(`)k ), (2.21)
where
w
(`)
k = w
(`)
k|k−1
[
1− P detk (x(`)k ) +
∑
zk,m∈Zk
P detk (x
(`)
k )p(zk,m|x(`)k )
ζ(Zcltk ) + Ck(Zk)
]
(2.22)
and
Ck(zk,m) =
Np+Nq∑
`=1
w
(`)
k|k−1P
det
k (x
(`)
k )p(zk,m|x(`)k ). (2.23)
This enables us to estimate the state parameters at any time step from the particle
approximation at the previous time step. The PHDF is able to track multiple objects
and estimate the number of objects present. The final localization at each time step
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requires finding the peaks of the PHD. This can be done in a few ways, but the most
straightforward is to take the estimated number of objects from summing the weights,
and use a Gaussian mixture model or k-means clustering to find the clusters within
the particles. It is an algorithm used often in radar and sonar applications, but can
be applied to the neural tracking problem as long as separate measurements can be
provided. Obtaining good separation from the ICA algorithm is critical. Pseudocode
for the particle filter implementation of the PHDF is provided in Algorithm 3.
2.3.3 OSPA Error Metric
Since the PHDF must estimate the number of objects, the mean square error is not
directly applicable. Different error metrics on random finite sets have been proposed,
including the OSPA metric [108]. The OSPA metric was proposed with the intent
of improving the OMAT metric [109], which it uses within. The OSPA metric takes
in two sets and uses the OMAT metric to determine the best association in terms of
distance between the elements of the set, though if the sets have different sizes, some
elements of the larger set are not associated to any element of the smaller set. The
distance between each associated pair is computed, and the distance is set to infinity
for the unassociated elements of the larger set. Each distance is then compared to
a user specified threshold c, and the minimum of the absolute value of the distance
and c is kept. These values are then raised to a user specified power p, averaged,
and pth-rooted to obtain the final OSPA metric. The cutoff can be thought of as the
distance past which an element of the set is considered unassociatable. It is presented
in Algorithm 4. Choosing order p = 2 resembles an RMSE.
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Algorithm 3 Particle Implementation of the Probability Hypothesis Density Filter.
Initialization
. Define number of particles per continued object, N , and for new objects Nq
. Make initial guess about number of objects Tˆ0
. Sample Np,0 = N Tˆ0 particles x
(`)
0 ∼ p(x0) {chosen uniform over expected state
values}
. Compute associate weights w
(`)
0 = Tˆ0/Np,0, ` = 1, . . . , Np,0
while k ≤ K do
Prediction Stage {K is the maximum time step}
. Predict the state for each particle according to x
(`)
k = x
(`)
k−1,resamped + u
(`)
k−1
. Draw Nq particles for new objects {chosen uniform over expected state
values}
. Calculate the prediction weights,
w
(`)
k|k−1 =

w
(`)
k−1,resampled[Pk|k−1(x
(`)
k−1)], ` = 1, ..., Np,k−1
ν
Nq
, ` = Np,k−1 + 1, ..., Np,k−1 +Nq
Update Stage
. Maintain particle x
(n)
k
. Update corresponding weight
w
(`)
k = w
(`)
k|k−1[1− P detk (x(`)k ) +
∑
zk,m∈Zk
P detk (x
(`)
k )p(zk,m|x(`)k )
ζ(Zcltk ) + Ck(Zk)
] (2.24)
. Calculate the estimated number of objects, Tˆk =
∑Np,k−1+Nq
`=1 w
(`)
k
. Find Tk, which is Tˆk rounded to the nearest whole number of objects
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Resampling Stage
. Divide all particle weights by Tˆk
. Calculate Np,k = N Tk
. Evaluate the cumulative sampled distribution cn
. Draw threshold d0 from a uniform distribution between 0 and 1/(Np,k)
. Initialize m = 1 and n = 1
for m = 1 : Np,k do
dm = d0 + (m− 1)/(Np,k)
if cn ≥ dm then
Replicate the particle
x
(m)
k,resamped = x
(n)
k
w
(m)
k,resamped = Tˆk/Np,k
Set m = m+ 1
else
Discard the particle
Set n = n+ 1
end if
end for
. x
(m)
k = x
(m)
k,resamped, m = 1, ..., Np,k
. w
(m)
k = w
(m)
k,resamped, m = 1, ..., Np,k
. Set k = k + 1
end while
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Algorithm 4 OSPA Metric.
Inputs: Two sets X = {x1, ...,xM} and Y = {y1, ...,yN}, whose elements are
vectors of the same size, N ≥M
d(x,y) is a distance metric
Πk is the set of all permutations of {1,2,...,k}
c > 0 is a distance cutoff
d(c)(x,y) = min(c, d(x,y))
Final metric:
d
(c)
p (X,Y) =
(
1
n
(
min
pi∈Πm
m∑
i=1
d(c)(xi,ypi(i))
p + cp(m− n)
))1/p
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Chapter 3
NEURAL ACTIVITY ESTIMATION AND ARTIFACT SUPPRESSION
3.1 Neural Activity Dipole Source Model
The fundamental mechanics of brain function are fairly straightforward. Special
cells called neurons activate, firing electric currents called action potentials, in re-
sponse to other neurons and electrochemical conditions. Coordinated neuron activity
controls every brain function, from giving instructions to muscles to considering the
mysteries of the universe. These clusters of neural activity can each be modeled as
single dipole current sources. Kirchoff’s current law requires that the net current
within the head must be zero, so the dipole’s local primary current must be closed to
a weaker volume current throughout the brain, skull, and scalp [11, 22, 23]. Brain cur-
rent then generates an electric potential and magnetic field that can be measured with
a sensor net. The goal is then to solve for the parameters of the current that generated
the field, though it is a challenge to do so. [11]. The solution is not unique [11], as a
continuous distribution is sampled at the sensor locations, and the Nyquist theorem
on the spacial frequencies present cannot be guaranteed. One method, the one used
in this work, uses the assumption that the neural currents are accurately modeled as
dipole sources to look for the unique solution that then arises [11, 23, 110].
A current density, Jn, formed by neuron current in the head generates a measure-
ment vector of electric potentials. The forward problem is solved by calculating the
potentials at the electrodes when given an electrical source. The number of dipole
sources can vary as the brain performs different tasks. Mathematically, L dipolar
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current sources form a current density at time n of [11, 110]
Jn =
L∑
l=1
δ(r− rn,l) θn,l, (3.1)
where rn,l = [r
(x)
n,l r
(y)
n,l r
(z)
n,l ]
T and θn,l = [θ
(x)
n,l θ
(y)
n,l θ
(z)
n,l ]
T are the position and moment,
respectively, of the lth dipole source in the brain. In this model, the amplitude, sn,l,
and orientation, qn,l = [q
(x)
n,l q
(y)
n,l q
(z)
n,l ]
T are folded into the moment θn,l. The moment is
then given by θn,l = sn,l qn,l. We model the head as concentric spheres for the brain,
cerebral fluid, skull, and scalp and use the static equations of electromagnetics due to
the low frequency nature of the electroencephalogram (EEG) and magnetoencephalo-
gram (MEG) measurements [11]. The dipole sources then generate measurements
according to the Biot-Savart law, Ohm’s law, and the definition of electric potential.
The Biot-Savart law for the magnetic field at time n, Bn(r), for a region V and
current density Jn(r
′) is [11]
Bn(r) =
µ0
4pi
∫∫∫
r′∈V
Jn(r
′)× (r− r
′)
|r− r′|3 dr
′, (3.2)
where µ0 is the permittivity of free space and (a × b) denotes the cross product
between vectors a and b. We assume an isotropic current flowing through the layers
of the head with conductivity σs(r) for the brain, skull, and scalp [2], and that the
current generates an electric field at time n, En(r). Using Ohm’s law,
Jn(r) = σn,s(r) En(r). (3.3)
The electric potential and electric field are related as follows:
Vn(r) =
∫
C
En(r
′) dr′. (3.4)
Combining these equations forms a model for the measurements obtained from neural
currents. The measurements can be placed in vector form: [22, 23, 110]
yn = Ansn + vn, (3.5)
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where yn is an M × 1 column vector of measurements, M is the number of sensors,
An is an M ×L lead-field matrix that is a function of the positions rn,l and moments
θn,l of the L dipoles, sn = [sn,1 . . . sn,L]
T is an L × 1 column vector of the dipole
amplitudes, and vn is an M × 1 column vector of measurement noise, all at time
n [22, 23, 110].
EEG and MEG have different models for An. In the case of EEG, the elements
an,m,l, mapping dipole l to sensor m at time n, which compose matrix An in the case
of a single sphere model, are [22, 23, 110, 111]
an,m,l =
1
4piσs
cos(αn,l)
[
2
d3n,m,l
(|rn,l| cos(γn,m,l)− r)+ 1|rn,l|dn,m,l − 1|rn,l|r
]
(3.6)
+
1
4piσs
sin(αn,l) cos(βn,m,l) sin(γn,m,l)[
2r
d3n,m,l
+
dn,m,l + r
r dn,m,l(r − |rn,l| cos(γn,m,l) + dn,m,l)
]
.
The elements of the lead-field matrix for MEG, An, are [22, 23, 110, 111]
an,m,l =
[
µ0
4pif(rn,l, rm)2
(
f(rn,l, rm)θm × rn,l − θm × rn,l · rmF(rn,l, rm)
)]T
qn,l,(3.7)
where the position relative to the origin and moment of the M sensors are rm and
θm respectively, rn,l is the position of dipole l relative to the center of the sphere at
time n, qn,l is the orientation of dipole l at time n [22, 23, 110, 111], r is the radius of
the spherical head model, dn,m,l is the distance between dipole l and sensor m, γn,m,l
is the angle between rn,l and rm, αn,l is the angle between rn,l and qn,l, and βn,m,l is
the angle between two planes, the plane formed by rl and qn,l and the plane formed
by rl and rm,
f(rn,l, rm) = dn,m,l(dn,m,l |rm|+ |rm|2 − rTn,l rm),
F(rn,l, rm) =
(
d2n,m,l
|rm| +
(rm − rn,l)T rm
dn,m,l
+ 2 dn,m,l + 2|rm|
)
rm
−
(
dn,m,l + 2 |rm|+ (rm − rn,l)
T rm
dn,m,l
)
rn,l,
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µ0 is the permittivity of free space, and σs is permeability. We use a four spherical
shell model, for brain, fluid, skull, and scalp, which is more complex. Figure 3.1
depicts an example of the relationship between the dipoles and sensors.
γ
α
d
γ
d
α
Sensor
(0,0,0)
Dipole
Figure 3.1: Demonstration of the Three-Dimensional Parameters Used in the EEG
Lead-Field Matrix Formulation, Created Using EEGLAB [2, 3].
Equation (3.5) can also be written as
yn =
L∑
l=1
h(rn,l,qn,l, sn,l) + vn, (3.8)
with h(rn,l,qn,l, sn,l) a highly nonlinear function of rn,l, but linear in qn,l and sn,l,
according to (3.5). It can also be written as
yn =
L∑
l=1
D(rn,l)qk,lsn,l + vn, (3.9)
where D(rk,l) isM×3 vector function of the dipole position rk,l, and Ak,l = D(rk,l)qk,l.
Estimating rn,l, qn,l, and sn,l for all times n and all L dipoles is referred to as the
inverse problem [11]. Next, we examine our use of particle filtering to solve the inverse
problem [22, 23].
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3.2 Dipole Source Parameter Estimation
In the simplest case for EEG source localization, we would obtain many separate
measurements, all of which are generated by single dipolar neural activity that we
want to track, we would know which measurement comes from which dipole, and we
would know that the number of dipoles does not change. Then we could directly use
the particle filter to estimate the source parameters, without requiring more advanced
algorithms. We will use independent component analysis as a tool to obtain separate
measurements, but we still have to account for a changing number of dipoles and
lack of association between dipole and measurement. This requires the use of the
probability hypothesis density filter (PHDF).
We assume that there are L dipoles at time step n, and that a raw EEG measure-
ment is obtained from M sensors placed over the head of the form
yn =
∑L
l=1 D(rn,l)qn,lsn,l+vn. Here, sn,l, rn,l = [r
(x)
n,l r
(y)
n,l r
(z)
n,l ]
T and qn,l = [q
(x)
n,l q
(y)
n,l q
(z)
n,l ]
T
are the lth dipole amplitude, position vector, and orientation vector, respectively, for
l= 1, . . . , L. The particle filter (PF) requires a state transition equation and mea-
surement equation of the forms in Equations (2.1) and (2.2) to obtain an estimate
of the dipole parameters. Determining the measurement equation involves taking
the EEG/MEG lead-field equations in (3.5) and finding a way to obtain separate
measurements from each dipole source, to match up to the model:
yn = Ansn + vn =
L∑
l=1
D(rn,l)qn,lsn,l + vn, (3.10)
where the elements of An for EEG and MEG are provided in (3.6) and (3.7), re-
spectively, sn is a column vector of dipole amplitudes, and vn is measurement noise.
Then, each column of An can we written as An,l = D(rn,l)qn,l.
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3.2.1 Independent Component Analysis
The measurements obtained from EEG/MEG contain a mixture of all of the neural
activity. Separating them into measurements from individual sources is difficult. A
method used by the group who made the EEG processing program EEGLAB [2] is
independent component analysis (ICA). This method is based on finding the most
temporally independent components in the data. It can be applied to EEG since the
time courses of dipoles in different areas of the brain should be independent, even
if there is a causal relationship between activity. Some use of ICA on EEG data
can be found in [2, 49, 112]. ICA finds individual measurements that have removed
the large dependencies that appear in the sensors across the head. They should
tend to correspond to particular sources, allowing us to use them in the particle
filter to estimate the dipole position, orientation, and amplitude parameters [22, 23].
ICA maximizes temporal independence using one of several possibilities, including
minimizing the mutual information as well as maximizing the non-Gaussianity of the
data using metrics like the kurtosis of the sources. In order to apply ICA, we need
a segment of data on which the dipole position and orientation are approximately
constant.
Not all of the separated components come from brain activity, however. There
can be other electrical activity that shows up on the EEG/MEG, including eye move-
ments, muscle movements, line noise from a power source, or electrodes popping.
These components can interfere with neural analysis unless they are suppressed. After
ICA, these components appear at the output of the ICA [113] and can be suppressed
with signal processing techniques.
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First, we inspect some data provided with EEGLAB and see the results of using
ICA. The provided real data comes from a visual reaction experiment, and has the
following description on the EEGLAB wiki [114]:
In this experiment, there were two types of events “square” and “rt”;
“square” events correspond to the appearance of a green colored square in
the display and “rt” to the reaction time of the subject. The square could
be presented at five locations on the screen distributed along the horizontal
axis. Here we only considered presentation on the left, i.e. position 1 and
2 as indicated by the position field (at about 3 degree and 1.5 degree
of visual angle respectively). In this experiment, the subject covertly
attended to the selected location on the computer screen responded with
a quick thumb button press only when a square was presented at this
location. They were to ignore circles presented either at the attended
location or at an unattended location. To reduce the amount of data
required to download and process, this dataset contains only targets (i.e.,
“square”) stimuli presented at the two left-visual-field attended locations
for a single subject [114].
The data comes with markers for events, including the presentation of the visual
cue. Using these markers, we select a three second segment that begins one second
before the cue, and two seconds after. There are 80 such intervals, giving 240 sec-
onds of data with 32 sensors placed over the head. The sensor locations are shown
in three-dimension (3-D) and in a two-dimensional (2-D) projection in Figure 3.3.
Detrending, baseline removal, and average referencing follow the procedure on the
EEGLAB wiki [114]. We first run ICA on the full 240 second interval and examine
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the components that arise. Three “epochs,” which are the three second segments
around each visual cue, are shown in Figure 3.3 [2].
EOG1
F3  Fz  F4  
EOG2
FC5 FC1 FC2 
C3  C4  Cz  T8  
CP5 CP1 CP2 
P3  Pz  P4  
P8  
PO3 POz PO4 PO8 
FPz 
FC6 
T7  
CP6 
P7  
PO7 
O1  Oz  O2  
Figure 3.2: Diagram of EEG Sensor Locations, Created Using EEGLAB [2, 3].
The third interval appears to include an artifact as there is a large spike around a
half second into the interval. It is most prominent in channels at the top of the plot,
which tend to be near the front of the head, so the strongest potential is found near
the face, indicating the presence of an eye-related artifact. The way that the signal
rises and falls to the same level indicates an eye blink instead of a movement [38].
Using ICA, we separate the artifact component using the linear transformation used
by the algorithm to obtain independent components [112]. The creators of EEGLAB
have had success in using ICA to separate artifacts, even though ICA does not use
information about the underlying neural model [49, 112]. Figure 3.4 shows the final
resulting ICA components. The spike observed before appears to have separated out
to component 6. The blink also appears in the same component more times over all
epochs. Some more artifacts appear in the final components. There is another eye
artifact in component 10, though its amplitude is different before and after the jump,
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Figure 3.3: EEG Readings from Channels around Visual Stimulus from -1 to 2 s,
Created Using EEGLAB [2, 3].
which is more likely to be an eye movement than a blink [38]. Component 28 is a
jump that looks like an electrode pop or some other temporary mean shift but does
not show up clearly in the original data. A useful way to examine artifacts is to plot
the mixture coefficients at each sensor to try and identify the location of the current
generating the component. Figure 3.5 and Figure 3.6 show these plots for components
6 and 10, respectively. The large mixture coefficients near the eyes are clear. This
strongly indicates their classification as eye artifacts. Once the measurements are
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separated, the PF algorithm can be applied as the measurements are associated to
their corresponding sources.
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Figure 3.4: EEG Readings of 32 Independent Components around Visual Stimulus
from -1 to 2 s, Created Using EEGLAB [2–4].
3.2.2 Particle Filter Tracking of a Known Number of Neural Sources
As stated before, to apply ICA, an interval on which the dipole position and
orientation are approximately constant is required. We assume that this is true on
intervals of length L, so that the matrices from Equations (3.6) and (3.7) can be
constructed. We have An ≈ Ak for n = (k − 1) ∗ L + 1, ..., k ∗ L, and we extract
36
  
−
+
Figure 3.5: Strength of Channels in Independent Component 6, Created Using
EEGLAB [2–4].
Lk separated measurements at a particular time interval k, where k = 1, ..., K. We
denote these separated measurements as ζk,l for l = 1, ..., Lk. These are extracted
via ICA on the raw measurement {yk∗L+1, ...,y(k+1)∗L}. With the modification of the
measurement equation in terms of the separated measurements and the separated
state vectors xk,l, the state parameters of the lth dipole at time interval k becomes
ζk,l = Ak,lsk,l + vk,l = B(rk,l)qk,lsk,l + vk,l, (3.11)
where Ak,l is the lth column of the EEG/MEG matrix from Equations (3.6) and
(3.7), sk,l is the 1×L time course on independent component l, and vk,l is a Gaussian
noise vector. ICA provides an estimate of the Ak matrix and separated signals sk.
In the particle filter, we can use Ak,l to estimate the lth dipole position, rk,l. We
can use sk,l to discriminate brain activity from artifacts, since the amplitude contains
frequency information and the overall waveform of the independent components. We
assume that σk,l is a vector of features that are functions of sk,l and discriminate
brain activity from artifacts. If the measurement does not include artifacts and the
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Figure 3.6: Strength of Channels in Independent Component 10, Created Using
EEGLAB [2–4].
measurement to source association is known, the lth dipole measurement vector for
the particle filter is simply zk,l = Ak,l + nk,l, where Ak,l is the lth column of the
mixture matrix Ak, and nk,l is Gaussian noise. Note that, in general a Gaussian
model is not required as the particle filter allows for non-Gaussian noise. When
features are incorporated, denoted as σTk,l, that discriminate neural activity from
artifacts, we have zk,l = [A
T
k,l,σ
T
k,l]
T + nk,l. This gives a model probability density
function (pdf) for neural activity. We denote the measurement vector pdf for brain
activity as p(zk,l|xk,l), with xk,l = rk,l. This equation is used during the weight update
in the particle filter, applying the forward model to solve the inverse problem. We
assume that the dipoles remain in a local region for as long as they continue to exist.
New dipoles may arise and old dipoles may vanish, but for a dipole to be considered as
a single dipole moving, it should stay around a particular lobe of the brain. Thus, we
apply a random walk model as the state transition equation. Thus, for each particle,
x
(n)
k,l = x
(n)
k−1,l + uk,l, with uk is assumed zero-mean Gaussian. The final state model
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becomes
xk,l = xk−1,l + uk−1,l, (3.12)
and our measurement model:
zk,l =
Ak,l
σk,l
+ nk,l =
D(xk,l)qk,l
σk,l
+ nk,l . (3.13)
This results in
p(zk,l|xk,l,qk,l) ∼ N

D(xk,l)qk,l
µσ
 ,CN
 , (3.14)
where µσ is the model mean for the frequency discrimination features for targets,
and CN is the model noise covariance. For use in the PF, we approximate p(zk,l|xk,l)
using with maximum likelihood estimation, as
p(zk,l|xk,l) ≈ p(zk,l|xk,l, qˆk,l) ∼ N

D(xk,l)qˆk,l
µσ
 ,CN
 , (3.15)
where qˆk,l = (D(xk,l)
TD(xk,l))
−1D(xk,l)Tzk,l by least squares. These models are
applied directly to the particle filter, probabilistic data association filter (PDAF) and
PHDF in Algorithms 1, 2 and 3, respectively, in Chapter 2.
3.2.3 Tracking an Unknown Number of Sources
The particle filter can track neural activity sources for a fixed and known number
of sources when the association of measurement to source is known. If this association
is not known, the PDAF can be used to perform the tracking. However, it is often
the case that the number of sources varies over time, which is not accounted for
by the PDAF algorithm. When the number of sources varies with time, the PHDF
can be used as it can estimate the number of sources at different time steps [22, 23,
39
36, 37, 85, 86]. Some results using the PHDF in our research group can be found
in [22, 23, 36, 37, 115].
3.3 Artifact Suppression
3.3.1 Characterization of Artifacts
After applying ICA to EEG data, we obtain separate measurements, some of which
originate from neural activity, and some of which originate from other non-neural elec-
trical activity. The measurements that originate from non-neural electrical activity
are artifacts that need to be suppressed before tracking neural sources. There are
many kinds of artifact signals, and many different methods were designed to identify
or suppress them [38–48]. Physiologic artifacts include muscle movements, breath-
ing and heartbeat, while non-physiologic artifacts include the signal leaking from the
power line, electrode popping, sweat on the electrode, or movement of the patient or
bed. The artifact measurements can reduce the neural source estimation performance
of the tracker unless methods are integrated with the tracker to account for the spuri-
ous artifact measurements. Some methods used for artifact suppression include ICA
followed by pattern recognition [39, 49], wavelets [45], regression techniques [41], and
using principle component analysis along with minimum norm estimation [40]. Noise
canceling filters were used in real time in [47, 48] and blind source separation was
applied in [46].
We considered artifact characteristics by inspection in order to obtain a model for
the artifact distribution for use in the measurement model. Using the real dataset
provided by EEGLAB [114], we developed a model for discriminating between neural
activity and artifacts. The model depends on the amplitude parameter vector sk,l,
though it is possible to incorporate the leadfield components in Ak,l as well. Our
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chosen artifact discrimination statistic for the measurement model in Equation (3.13)
is given by
σk,l =
∫ 25
4
|Sk,l(f)|2df∫ 4
0
|Sk,l(f)|2df +
∫ 64
25
|Sk,l(f)|2df
, (3.16)
where Sk,l(f) is the Fourier transform of sk,l(t). The model statistic is computed by
approximating the integrals with sums, and it assumes that the neural source activity
occurs between 4 Hz and 25 Hz in the frequency domain.
3.3.2 Suppression of Artifacts Based on Data Association
Our artifact suppression method is based on the use of the probabilistic data asso-
ciation filter (PDAF) after the EEG recordings are processing using ICA [3, 4]. The
PDAF accounts for spurious measurements in its model by assuming measurements
are not associated to sources, and it allows for some measurements formed by arti-
facts. Models for sources and artifacts are required, so we form an artifact model
based on the frequency domain properties of the artifacts, as in the previous section.
The PDAF uses the model to decide whether the measurements are more likely to be
sources than artifacts before estimating the source locations. Note that our approach
does not require any further pre-processing of the measurements after ICA, unlike
other methods that require pre-processing to suppress artifact components before
tracking.
The artifact model we considered in Equation (3.16) takes into consideration that
the neural activity based measurements have high power in the alpha and beta fre-
quency bands. We assume that the patient is awake, so there is not significant low
frequency delta waves, which are strong during sleep [116]. We thus assume that
strong power in very low frequencies is likely caused by eye artifacts, which have
strong low frequency content. Using this frequency-based characterization for arti-
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facts and neural activity, we can obtain estimates of the mean and variance of the
discrimination statistic as well as the leadfield values for sources and artifacts needed
for use in the PDAF model [4]. For the PDAF algorithm, described in Chapter 2, we
model the artifacts as clutter distributed uniformly over the the measurement region;
λ is the average number of artifacts and % is the average density in the measurement
space that is calculated using the volume of the measurement space where artifacts
take on values, V . In the EEG model, the measurements consist of a column vector
of mixture coefficients Ak,artifact appended with an artifact discrimination statistic
σk,artifact. Denote the range of values the mixture coefficients ak,m,artifact take on for
M sensors as arange,artifact, and the range of values the the discrimination statistic
takes on for artifacts as σrange,artifact Then, the uniform volume artifact measurements
appear within, V = (arange,artifact)Mσrange,artifact. Then, % = λV . Plugging % into the
PDAF allows for tracking neural sources while suppressing artifacts [4].
3.4 Tracking Performance for an Unknown Number of Neural Sources with
Artifacts
We test this algorithm on synthetic data [4]. This data is sampled at 1,024 Hz. We
place 2 dipole sources uniformly over the model head region, an upper hemisphere
of radius 85 mm. Their position and orientation are unchanged over second long
intervals, which is the duration of a particle filter time step. Their orientation is
uniformly distributed over all possible angles at each second long set of 1,024 samples.
Each position is updated every second with a 10 mm random walk, but prevented
from leaving the hemisphere. Each source has an amplitude that varies in time at
each sample.
Each of the synthetic sources and synthetic artifact signals are assumed to have two
frequency components to make the sources temporally independent. One frequency is
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within the range of neural activity frequencies, between theta and low beta frequencies
(4 Hz to 25 Hz) [116]. Each source and artifact also has a frequency below 4 Hz or
above 25 Hz up to 64 Hz. The frequency range can be different for each artifact and
change over time; both frequencies stay the same over time for the sources.
To form the model pdf of the discrimination function, σk,l, for sources and arti-
facts, we used the real EEG data provided on the website with EEGLAB [114]. We
performed ICA over 240 seconds of data, and we used the scalp maps, the residual
variance from the DIPFIT model provided by EEGLAB [117], and the estimated po-
sitions from DIPFIT to manually separate the ICA components into neural activity
and artifacts. We estimated value for the discrimination function was 0.2 and 1.7 for
artifacts, and between 2 and 4 for neural activity.
In constructing the synthetic data, the discrimination function value was drawn
uniformly on the interval [2, 4] for sources, and from a normal distribution of mean 0.9
and variance 0.071 for artifacts. The frequency components are scaled appropriately
to fit the value. New artifacts are drawn at each time step, and the number of
artifacts is Poisson distributed with mean 2. The mixed measurements also included
some Gaussian noise. Note that ICA decomposition adds additional error and is the
primary cause of separated measurement noise.
To determine the model parameters, we drew 4,000 components this way and
examined the signals obtained after ICA, comparing the true mixed signals to the ones
extracted by ICA, to determine the approximate artifact density and a reasonable
range for modeling the source measurement variance. For sources, the frequency
function is modeled as a normal distribution with mean 3 and variance 0.11, so that
the distribution falls on the interval [2,4]. The state model is a 10 mm random walk.
The principal component analysis dimension reduction threshold, which determines
the number of components ICA separates, was set based on test runs, so that the
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cutoff was placed at the “elbow” of the plot, where the steepness decreases suddenly
as the remaining eigenvectors extract noise. The probability of detection is set at
0.99.
We performed 100 Monte Carlo simulations of synthetic data with two sources,
with different sources each time. We present a plot of a typical run for two dipole
sources in Figure 3.7. In this plot, the hollow markers connected with solid lines are
the true positions, and the cross-shaped marked markers connected by dashed lines are
the estimates positions. The root mean-squared error (RMSE) for the source position
across the Monte Carlo runs is provided in Figure 3.8. The estimation error falls off
over time as the PDAF locks onto the sources, dropping below 8 mm, assuming a head
of radius 85 mm. Note that is difficult to ensure that signals are properly constructed
to be independent. The individual runs indicate that sources whose frequencies are
harmonic with other sources present more of a challenge for ICA.
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Chapter 4
ADAPTIVE CLUSTERING OF TASKS WITH NEUROSTIMULATION
4.1 Neurological Disorders and Neurostimulations
Recently, neurostimulation has been used to treat disorders such as Parkinson’s
disease and essential tremor. Patients with Parkinson’s disease suffer from severe
tremors as the disease progresses, slowly making movements more difficult. The
primary symptoms listed on the Mayo Clinic website are: “tremor, slowed movement,
rigid muscles, impaired posture and balance, loss of automatic movements, speech
changes, and writing changes [6].” The tremor tends to show at rest, and it can early
on take the form of rolling the thumb and first finger together. Shorter steps and
dragging feet are common. Parkinson’s disease patients can have reduced automatic
movements, possibly blinking less or no longer swinging their arms while walking.
Monotone voice or slurring of words can be a symptom, as well as loss of penmanship.
The disease can also bring dementia, depression, difficulty swallowing, sleep disorders,
bladder and digestive issues, loss of sense of smell, and other symptoms [6, 63, 65].
Parkinson’s disease is caused by the death of neurons that produce dopamine. The
lost dopamine directly causes the symptoms of Parkinson’s disease. The exact reasons
for the onset of Parkinson’s disease are not certain, but genetics and the environment
both play a role. It tends to affect men and usually develops at age 60 or older. It
is incurable, but the symptoms can be managed with medication. However, as the
disease advances, the medications can stop working as well as they worked when the
disease began. This is when a treatment called deep brain stimulation (DBS) can be
employed [6, 7, 53, 54].
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The treatment of Parkinson’s disease is very individualized, as treatments affect
everyone differently. Dopamine replacement can be performed with a combination
of levidopa and carbidopa. Over time, the symptoms return sooner after doses and
patients can experience significant “off” times before it is time for the next dose.
Some drugs can extend the duration of levidopa action when added to the treatment.
Dopamine mimics can also be used to manage symptoms and amantadine can reduce
tremors in some cases [6, 56].
There are also surgical techniques to manage the symptoms of Parkinson’s disease.
Older surgical techniques, such as pallidotomies and thalamotomies were replaced by
deep brain stimulation (DBS) [7, 55]. The older techniques left permanent lesions in
particular locations, as opposed to DBS, which is reversible and adjustable, charac-
teristics important to managing a changing disease like Parkinson’s disease [7]. Deep
brain stimulation uses a surgical implant that is reminiscent of a pacemaker for the
brain instead of the heart. Parkinson’s disease symptoms were shown to improve
after placing electrodes at particular points in the brain and applying certain wave-
forms electrically. Although DBS carries risks just like any other surgery, it is a
powerful technique for certain cases of Parkinson’s disease, such as those with severe
medication side effects [6, 7, 53, 54].
Research on Parkinson’s disease using electroencephalogram (EEG) measurements
suggest possible changes in the signal power both in the beta band (13 - 30 Hz) and
gamma band (30 - 100 Hz) frequencies [16, 28, 57–67]. In particular, significant
fluctuations in beta power were observed during motor and language tasks in [67].
Repetitive motion tasks and tasks with both speech and motor caused significant
increases in beta power, and these tasks can make the Parkinson’s disease tremors
more evident. These beta power changes seem to be related to the pathology of
Parkinson’s disease [16, 28, 57–67].
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In the next section, we present some clustering methods that we apply to discrim-
inate different tasks performed by Parkinson’s disease patients in later sections.
4.2 Clustering Approaches
4.2.1 Gaussian Mixture Modeling
The Gaussian mixture model (GMM) is fundamentally a probabilistic model for
measured data that considers that all possible measurement vectors x are obtained
from a finite number of Gaussian distributions whose parameters need to be estimated.
The multivariate Gaussian pdf over a k-dimensional space has two parameters, the
mean, µ ∈ Rk and covariance, C ∈ Rk×k, where R is the set of real numbers, and is
given by
p(x;µ,C) =
1
(2pi)(k/2)det(C)(1/2)
exp(−1
2
(x− µ)TC−1(x− µ)), (4.1)
where det(C) is the determinant of matrix C. A Gaussian mixture model is just a
weighted combination of Gaussian pdfs. If there are M components on the GMM,
then we consider the indicator variable zm,m = 1, ...,M , such that only one indicator
variable is 1 and the others are 0. The weight of the mth Gaussian pdf is then given
by αm = Pr(zm = 1), where Pr(·) denotes probability. As the GMM is also a pdf, all
the weights add to 1,
∑M
m=1 αm = 1, and the pdf of the GMM can be written in the
k-dimensional space using Θ = {α1, ..., αM ,µ1, ...,µM ,C1, ...,CM}, as
p(x|Θ) =
M∑
m=1
αm
(2pi)(k/2)det(Cm)(1/2)
exp(−1
2
(x− µm)TC−1m (x− µm)), (4.2)
or more compactly as
p(x|Θ) =
M∑
m=1
αmp(x|zm,µm,Cm), (4.3)
with
p(x|zm,µm,Cm) = 1
(2pi)(k/2)det(Cm)(1/2)
exp(−1
2
(x− µm)TC−1m (x− µm)). (4.4)
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The GMM can be used as a classifier for different measurements xn, n = 1, . . . , N ,
by calculating a classification weight for xn for each of the M GMM components.
The GMM construction does not make a hard decision until the very end, when the
highest classification weight indicates in which class to assign the measurement. The
weights can be found using Bayes’ rule for each data point xn and class m as:
wnm = Pr(znm = 1|xn,Θ) = pm(xn|zm,µm,Cm)αm∑M
`=1 p`(xn|z`,µ`,C`)α`
. (4.5)
Using the GMM for classification requires that the number of classes, M , is known.
However, the exact type of each of the M classes is not required, thus leading to an
unsupervised classifier that does not require training. The algorithm to find the
GMM looks to maximize the probability of receiving the data set from the GMM
pdf. This is done approximately using the expectation maximization (EM) algorithm
that is provided in Algorithms 5 - 7. The stopping criteria of the EM is when the log-
likelihood changes less than a certain threshold between iterations. The log-likelihood
at iteration j is lj =
∑N
n=1 log[p(xn|Θ)]
Note that the derivation here mirrors the one in [93].
4.2.2 Dirichlet Process Gaussian Mixture Models
As discussed in Section 4.2.1, the GMM algorithms requires knowledge of the num-
ber of classes when used for clustering the provided measurements. In many cases,
however, the number of classes is unknown. As such, we employ the Dirichlet Process
Gaussian Mixture Model (DP-GMM) [94–102]. Since the DP-GMM decides the num-
ber of classes itself, it can reclassify when new data is provided. This is important for
our application as it can be used to monitor changes in the patient’s brain activity.
The Dirichlet process can be thought of as a distribution on distributions [97]. Draws
from a Dirichlet process generate discrete distributions almost surely. Specifically, we
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Algorithm 5 Expectation Maximization for Gaussian Mixture Model.
Initialization
{x1, ...,xN} is the data to classify
There are M mixture components
j = 0
Initialization option 1:
Start with all initial w0nm
Enter while loop at M step
Initialization option 2:
Start with all initial α0m,µ
0
m,C
0
m
Enter while loop at E step
while |lj − lj−1| ≤  do
Perform E step (Algorithm 6):
Perform M step (Algorithm 7):
Iteration:
j = j + 1
end while
Output GMM parameters at last iteration
Algorithm 6 Expectation (E) Step.
for n = 1 : N do
for m = 1 : M do
wjnm =
pjm(xn|zjm,µjm,Cjm)αjm∑M
`=1 p
j
`(xn|zj` ,µj` ,Cj`)αj`
end for
end for
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Algorithm 7 M Step.
for m = 1 : M do
N jm =
∑N
i=1 w
j
nm
end for
for m = 1 : M do
αjm =
Njm
N
end for
for m = 1 : M do
µjm =
1
Njm
∑N
n=1 wnm xn
end for
for m = 1 : M do
Cjm =
1
Njm
∑N
n=1wnm(xn − µm)(xn − µm)T
end for
consider a Dirichlet process G as
G ∼ DP (α,G0), (4.6)
where α is called the concentration parameter and G0 is some base distribution,
which may be continuous. In clustering applications, this is a distribution on a
vector of parameters. For the a DP-GMM, it is a distribution on the means and
covariances for the mixture components. The mixture model has some distribution
that is parameterized by values that are in the space that G0 is defined on. A way to
visualize the Dirichlet Process (DP) is by using the description of a Chinese restaurant
process [97–99]. It proceeds as follows: there is a restaurant (the space that the base
distribution is defined on) with tables (points in the space) for customers to sit at.
Each new customer may join any table or start a new one. The probability of starting
a new table is proportional to the concentration parameter, α, and the probability to
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join an existing table is proportional to the number of customers already there. The
process starts with the first customer selecting a table (a draw from G0 is made, which
is one of the discrete points in the distribution G). The second customer may join
this table with probability 1
1+α
or select a new one with probability α
1+α
. If the second
customer joins the first table, then the probability for customer three to join the first
table (a weight is added to the point) is 2
2+α
, and to select a new table (a new point is
drawn from G0) is
α
2+α
. If the second customer formed Table 2, then the probability
to join Table 1 is 1
2+α
, to join Table 2 is 1
2+α
, and to select a new table is α
2+α
.
This process continues, providing a clustering effect and a discrete distribution that
resemblesG0. The cluster associations are drawn for theN measurements to construct
mixture components. This construction makes G a discrete probability distribution
for clusters: each point with non-zero probability in G gives the parameters for a
component in the mixture model distribution, and the probability at that point is
the weight of that distribution within the mixture model. A measurement drawn
from a mixture model can be obtained by first drawing which mixture component it
came from, and then the measurement is drawn from the distribution specified by
the mixture component parameters. The parameters correspond to the means and
covariances for the DP-GMM, so that the nth draw from G is
θn|G ∼ G, n = 1, ..., N, (4.7)
with θn = [µn,Cn], associated to each measurement and not unique, due to the
discreteness of G.
The measurement set, x1,x2, ...,xN can be drawn from each parameter vector,
which is also a cluster association due to the discreteness of G
xn|θn ∼ N (µn,Cn), n = 1, ..., N. (4.8)
52
Since an infinite mixture model can be described via the Dirichlet process, the
challenge then becomes to estimate the mixture components and weights. To start
with, we explicitly describe G, which has a simple stick-breaking construction:
G(θ) =
∞∑
m=1
wmδ(θ − θm). (4.9)
wm ∼ vm
m−1∏
i=1
(1− vi),m = 1, ...,∞. (4.10)
vi ∼ Beta(1, α), i = 1, ...,∞. (4.11)
θm ∼ G0,m = 1, ...,∞. (4.12)
with wm = Pr(θ = θm), and all θm are not associated to any measurement and
unique, being drawn from the continuous G0.
To make the construction more explicit, we eliminate G by introducing category
variables, cn, which associate the measurements xn to parameter vectors θm. Each
discrete point in G with non-zero probability is associated to a positive integer cat-
egory variable. We designate that discrete distribution on the counting numbers as
Discrete. This changes the final model of the data, xn, n = 1, ..., N to:
xn|cn ∼ p(xn|θcn), n = 1, ..., N. (4.13)
cn|w ∼ Discrete(w), n = 1, ..., N. (4.14)
wm = vm
m−1∏
i=1
(1− vi),m = 1, ...,∞. (4.15)
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vi ∼ Beta(1, α), i = 1, ...,∞. (4.16)
θm ∼ G0,m = 1, ...,∞. (4.17)
This construction allows the data points to be assigned to the most likely mixture
component. This way, the number of clusters does not have to be specified beforehand,
since a possibly infinite number of clusters can be used. Additionally, only a finite
number of clusters can have “large” weights, so for practical applications, the number
of clusters can be reduced to achieve a certain level of error. If N is the number of
data points and M is the number of clusters to truncate to, the truncation error is:
 = 4N exp(−(M − 1)/α). (4.18)
Note that the truncation limit should be higher than the number of clusters that
are reasonable for the data set, so that there are still clusters available to allow fair
movement through the space.
With a model established, we would like to estimate all of the parameter vectors
θm and associated weights wm for m = 1, ...,M , where M is the truncation limit
on the number of clusters, as well as each of the cluster associations for each data
point, cn for n = 1, ..., N , where N is the number of data points. Specifically, the
posterior distribution, p(θ1, ...,θM , c1, ..., cN , w1, ...wM |x1, ...,xN), needs to be approx-
imated. We can use the blocked Gibbs sampler [102, 118] to obtain samples from this
distribution indirectly, under certain conditions. In order to do so, we start with
some initial guess for all of the random variables involved, then sample certain blocks
of random variables from their distribution conditioned on all of the other random
variables and the data. A new sample is obtained after one full cycle of conditional
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sampling. After a sufficient burn-in period, the samples will explore the posterior dis-
tribution. We can then use these samples to estimate all of the means, covariances,
weights, and associations. One possible order is as follows: for iteration i,
θ(i)m ∼ p(θm|c(i−1)1 , ..., c(i−1)M ,x1, ...,xN),m = 1, ...,M. (4.19)
c(i)n ∼ p(cn|θ(i)1 , ...,θ(i)M , c(i−1)1 , ..., c(i−1)M ,x1, ...,xN), n = 1, ..., N. (4.20)
w(i)m ∼ p(wm|c(i)1 , ..., c(i)M ),m = 1, ...,M. (4.21)
Some simplifications from conditional independence have been applied. By choos-
ing conjugate priors, we can obtain the following:
p(θm|c1, ..., cM ,x1, ...,xN) ∝ G0(θm)
∏
n:cn=m
p(xn|θm),m = 1, ...,M. (4.22)
p(cn|θ1, ...,θM , w1, ..., wM ,x1, ...,xN) =
M∑
m=1
(wmp(xn|θm)) δ(cn −m),
n = 1, ..., N.
(4.23)
p(vm|c(i)1 , ..., c(i)M ) = Beta(1 +N∗m, α +
M∑
m′=m+1
N∗m′),m = 1, ...,M. (4.24)
wm = vm
m−1∏
j=1
(1− vj),m = 1, ...,M. (4.25)
In these expressions, n : cn = m is the values of n such that cn = m, N
∗
m is the
number of such values of n, and α is the concentration parameter. The pdf for the
Beta distribution is: p(x; a, b) = x
(a−1)(1−x)(b−1)Γ(a+b)
Γ(a)Γ(b)
. The conjugate prior for means
and covariances is the Normal-Wishart distribution, NW . By using that as the prior
for θ, the prior and posterior conditional distributions are:
G0(θ) ∼= NW(µ,Σ−1;µN , τN ,ΨW , νW), (4.26)
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p(θ|c1, ..., cM ,x1, ...,xN) ∼= NW(µ,Σ−1; µ˜N , τ˜N , Ψ˜W , ν˜W). (4.27)
Here, µN is a real vector of length N , τN is positive and real, ΨW is an N × N
precision matrix, and νW is the number of degrees of freedom, greater than N − 1.
The equations for µ˜N , τ˜N , Ψ˜W , and ν˜W are:
µ˜N =
τNµN +Nµx
τN +N
, (4.28)
τ˜N = τN +N, (4.29)
Ψ˜W = ΨW + Σx +
τNN
τN +N
(µN − µx)(µN − µx)T , (4.30)
and
ν˜W = νW +N, (4.31)
where µx and Σx are the mean and covariance of the data, x1, ...,xN . Algorithm 8
describes the blocked Gibbs sampler algorithm, following [97].
Much of the notation is borrowed from [95–97]. A deeper discussion of the DP-
GMM can be found in [100–102].
4.3 Clustering Behavior Tasks of Parkinson’s Disease Patients
4.3.1 Neural Signals and Time-Frequency Features
As discussed in Section 4.1, Parkinson’s disease patients that have undergone
DBS may suffer from cognitive, speech, and balance side effects. By customizing
DBS therapy to a patient’s task, these stimulation side effects may arise only when
they are non-detrimental to the patient’s current goals. It is thus important to be
able to use adaptive learning methods to identify different behavioral tasks of patients
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Algorithm 8 Blocked Gibbs Sampler for Dirichlet Process Gaussian Mixture Model.
Inputs: Data X = {x1, ...,xN} with each vector dimension k, Dirichlet process
innovation parameter α, DP cluster truncation value M , Normal-Wishart hyper-
parameters µN , τN ,ΨW , νW .
Outputs: L (specified) samples of {µ(i)m ,σ−1(i)m , c(i)m , w(i)m } for m = 1, ...,M .
Loop for some duration of burn-in followed by useful samples as required, Gibbs
iterations i=1,2,...
Update θ
(i)
m = {µ(i)m ,Σ−1(i)m } ∼ p(µm,Σ−1m |c(i−1),X),m = 1, ...,M :
. Let Xm = {xn : c(i−1)n = m} and Nm = cardinality(Xm),m = 1, ...,M .
. For all m = 1, ...,M , compute:
µxm =
1
Nm
∑
n:c
(i−1)
n =m
xn (4.32)
Σxm =
1
Nm
∑
n:c
(i−1)
n =m
(xn − µxm)2 (4.33)
µ˜N ,m =
τNµN +Nmµx
τN +Nm
(4.34)
τ˜N ,m = τN +Nm (4.35)
Ψ˜W,m = ΨW + Σxm +
τNNm
τN +Nm
(µN − µxm)(µN − µxm)T (4.36)
ν˜W,m = νW +Nm, (4.37)
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. Draw sample Σ
−1(i)
m from Wishart distribution: W(Σ−1m ; Ψ˜W,m, ν˜W,m
. Draw sample µ
(i)
m from Normal distribution: N (µm; µ˜N ,m, Σ
(i)
m
τ˜N ,m
)
Update c
(i)
n ∼ p(cn|µ(i),Σ−1(i),w(i−1),X)n = 1, ..., N :
. Let qm,n ∼= w(i−1)m N (xN ;µ(i)m ,Σ(i)m ), n = 1, ..., N
. Normalize q′m,n =
qm,n∑M
m=1 qm,n
,m = 1, ...,M and n = 1, ..., N
. Draw sample c
(i)
n ∼ ∑Mm=1 q′m,nδ(cn,m), n = 1, ..., N
Update w
(i)
m ∼ p(wm|c(i)),m = 1, ...,M :
. Draw sample vm ∼ Beta(1 +N∗m, α +
∑M
m′=m+1N
∗
m′),
where N∗m ∼= cardinality({n : c(i)n = m}),m = 1, ...,M
. Evaluate w
(i)
m = vm
∏m−1
j=1 (1− vj),m = 1, ...,M.
with Parkinson’s disease. In particular, local field potential (LFP) signals, collected
during DBS implantation surgeries when a patient is performing various tasks, can
be clustered and used to monitor changes in the severity of the patient’s disease.
LFP recordings are often performed with either invasive microelectrodes or DBS
leads and reflect oscillatory activity within nuclei of the basal ganglia. As long data
records are normally collected, relevant features are extracted and processed for clus-
tering to reduce computational complexity. As these signals are time-varying in na-
ture, task informative time-frequency based features can be extracted to provide
distinct patterns for the different behavior tasks. Such features can be obtained using
the matching pursuit decomposition (MPD) algorithm [119–121]. Using the MPD, a
signal can be decomposed into a linear expansion of Gaussian basis functions that are
selected from a redundant basic dictionary. The dictionary signals are time-shifted,
frequency-shifted and scaled versions of an elementary Gaussian atom; these basis
functions are chosen in order to best match the signal structure. The features ob-
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tained from the MPD are the time-shift, frequency-shift, scale change and weight
coefficient of each selected Gaussian in the signal expansion.
The MPD feature extraction algorithm is described as follows. We consider an
MPD dictionary D consisting of the Gaussian signals g(t; q) that are defined as
g(t; q) =
1
(pia)1/4
exp
(−(t− τ)2
2a
)
exp(−j2piν) , (4.38)
where q = [τ ν a]T , T denotes vector transpose, and τ , ν, and a are the time
shift, frequency shift, and scale change parameters, respectively, of a basic Gaussian
function located at the time-frequency origin. Using the iterative MPD, a continuous-
time signal x(t) can be decomposed after P iterations as [119]
x(t) =
P−1∑
p=1
αp gp(t) + rN(t) , (4.39)
where αp is the corresponding weight coefficient rP (t) is the remainder signal, and
gp(t) = g(t; qp) is the selected Gaussian signal with qp = [τp νp ap]
T . Using r1(t) =
x(t) for the first iteration, the best matched Gaussian signal gp(t) at the pth iteration
is selected such that it results in maximum correlation with the remainder signal.
Specifically,
gp(t) = arg max
g(t;q)∈D
∣∣∣∣∫ ∞−∞ rp(t)g(t; q)dt
∣∣∣∣ . (4.40)
The weight coefficient is thus given by
αp =
∫ ∞
−∞
rp(t)gp(t)dt , (4.41)
and the new remainder is rp+1(t) = rp(t) − αpgp(t). The algorithm can be stopped
when the remainder has sufficiently small energy.
The resulting feature vectors resulting from the MPD decomposition of x(t), as-
suming P MPD iterations, correspond to the 4-dimensional vector Fp = [αp qp]
T =
[αp τp νp ap]
T , for p = 1, . . . , P .
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4.3.2 Problem Formulation of Behavioral Tasks
We consider LFP signals, from Parkinson’s disease patients. The signals corre-
spond to tasks that describe four types of behaviors: simple motor task (m = 1),
language (m = 2), language with motor task (m = 3), and language without mo-
tor task (m = 4) [1]. The LFP signal set obtained from I experiments is given by
S = {s1i s2i s3i s4i }, where smi = [smi (1) . . . smi (K)]T , i= 1, . . . , I, corresponds to the
signal vector for the mth task, m = 1, . . . , 4, and smi (k) is the discretized LFP signal
from the mth task at time sample k, k= 1, . . . , K. The extracted MPD features for
the ith experiment is given by F = {F1i F2i F3i F4i }, where Fmi = [Fmi,1 . . . Fmi,P ]T is
the MPD feature matrix extracted from the LFP signal smi . The feature vector from
the pth iteration, p= 1, . . . , P , is Fmi,p = [α
m
(i,p) τ
m
(i,p) ν
m
(i,p) a
m
(i,p)]
T , corresponding to the
weight coefficient, time shift, frequency shift, and scale change parameters, respec-
tively. Using these extracted features for clustering, the mth cluster corresponds to
the mth task.
4.4 Adaptive Clustering Using Experimental LFP Signals
We consider a Parkinsonian LFP signal set provided by the Colorado Neurological
Institute [122]. The signal set was obtained from twelve Parkinson’s disease patients.
The signal segments associated with different behavioral tasks were labeled by physi-
cians during data collection. Equal numbers of experiments are taken for each task,
using a sampling rate of 4 kHz, collecting K = 2, 000 data samples for each LFP sig-
nal. The LFP signals are labeled based on the task the patient is performing by the
experimenter. As listed before, the tasks are: simple motor task (m= 1), language
with motor task (m= 3), and language without motor task (m= 4) [1]. Note that
Task 2 combines tasks 3 and 4.
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We performed adaptive clustering using the DP-GMM to classify Tasks 1, 3,
and 4. The presence or absence of a motor component of a task is important for
Parkinson’s disease because fine motor control is a challenge for the patients. The
data was collected with the DBS off, though obtained during DBS surgery. After
feature extraction, we determined that the best feature vector resulted by using the
weight coefficient and the time shift features, thus Fmi,p = [α
m
i,p τ
m
i,p ]. Figures 4.1(a),
4.2(a), and 4.3(a) show the contour plots of the DP-GMM model, displaying the
shapes of the DP-GMM classes, while Figures 4.1(b), 4.2(b), and 4.3(b) show the
weight distribution of the resulting DP-GMM classes. Tables 4.1, 4.2, and 4.3 show
the confusion matrices for the pairwise classifications. The parameters used in the
DP-GMM were set as: innovation parameter 0.6, truncation error = 1e− 2, number
of burn-in Gibbs iterations = 2000, and number of sampling Gibbs iterations = 1000.
Pred. Class 1 Pred. Class 3
True Class 1 0.92 0.08
True Class 3 0.22 0.78
Table 4.1: Confusion Matrix, Simple Motor m = 1 vs. Language with Motor m =
3 [1].
Pred. Class 1 Pred. Class 4
True Class 1 0.84 0.16
True Class 4 0.10 0.90
Table 4.2: Confusion Matrix, Simple Motor m = 1 vs. Language without Motor
m = 4 [1].
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(a)
(b)
Figure 4.1: (a) Contour Plot of DP-GMM Output for m = 1 (Simple Motor Task) vs.
m = 3 (Language with Motor Task). (b) Weight Distribution of the Two Classes [1].
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(a)
(b)
Figure 4.2: (a) Contour Plot of DP-GMM Output for m = 1 (Simple Motor Task)
vs. m = 4 (Language without Motor Task). (b) Weight Distribution of the Two
Classes [1].
63
(a)
(b)
Figure 4.3: (a) Contour Plot of DP-GMM Output for m = 3 (Language with Motor
Task) vs. m = 4 (Language without Motor Task). (b) Weight Distribution of the
Two Classes [1].
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Pred. Class 3 Pred. Class 4
True Class 3 0.96 0.04
True Class 4 0.28 0.72
Table 4.3: Confusion Matrix, Language with Motor m = 3 vs. Language without
Motor m = 4 [1].
The contour plot for classifying all three classes is shown in Figure 4.4(a). The
feature vectors resulting in the best classification, in this case, are Fmi,p = [τ
m
i,p a
m
i,p]
T ,
corresponding to time shift and scale change parameters. Figure 4.4(b) shows the
weight distribution of the three classes. Table 4.4 is the confusion matrix for the
three task classification.
Pred. Class 1 Pred. Class 3 Pred. Class 4
True Class 1 0.78 0.11 0.11
True Class 3 0.035 0.93 0.035
True Class 4 0.095 0.095 0.81
Table 4.4: Confusion Matrix, Simple Motor m = 1 vs. Language with Motor m = 3
vs. Language without Motor m=4 [1].
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(a)
(b)
Figure 4.4: (a) Contour Plot of DP-GMM Output for m = 1 (Simple Motor Task)
vs. m = 3 (Language with Motor Task) vs. m = 4 (Language without Motor Task).
(b) Weight Distribution of the Three Classes [1].
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Chapter 5
ADAPTIVE CLUSTERING WITH NEUROSTIMULATION ARTIFACT
SUPPRESSION
5.1 Structure of Deep Brain Stimulation Artifacts
The most common neurostimulation system currently available is deep brain stim-
ulation (DBS), an advanced surgical technique that provides substantial relief of the
motor signs of Parkinson’s disease. DBS can be used to alleviate motor symptoms
using high-frequency electrical stimulation when drug therapy is no longer sufficient
[53, 54]. Similar to the majority of neurostimulation systems, clinicians are able to
use one or a configuration of multiple electrodes to apply electrical stimulation to a
small target area. The stimulation uses a periodic waveform with short pulses, which
is characterized in the frequency domain by narrow spikes at the primary frequency
(130 Hz) and its harmonics. DBS leads are inserted into the target area with the
guidance of a stereotactic frame while patients are awake, allowing neurophysiolog-
ical recording of brain areas and intraoperative monitoring of electrical stimulation
side effects and clinical efficacy. New evidence demonstrates that neurostimulation
increases firing rates and induces synchronization of neurons in downstream nuclei
[123, 124]. This influence on communication between distant neuronal ensembles
[125, 126] may disrupt cortico-cortical and cortico-subcortical oscillatory synchroniza-
tion between connected brain regions, which form the basis of cognitive association,
decision making, and learning. Changes of the effect caused by neurostimulation can
determine whether variations to the stimulation waveform need to be made so that
it continues to alleviate disease symptoms.
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In order to be able to detect changes for monitoring the effect of DBS on Parkin-
son’s disease patients, it is important to adequately process electroencephalograms
(EEG) recordings obtained during DBS. However, DBS also causes artifacts in EEG
that preclude meaningful neurophysiological activity from being quantified during
stimulation. As the DBS artifact is generated entirely by the propagation of the DBS
waveform through the head, and does not originate from brain activity, the artifact
is independent of the patient paradigm and should be suppressed in order to improve
processing performance.
The stimulation frequency and its harmonics can be removed with a lowpass filter
as the EEG components at high frequencies are not necessary to the application [79].
Another frequency that must be suppressed using filtering is the the 60 Hz power line
frequency. The DBS artifact suppression technique needs to take into consideration
the narrow frequency domain spike nature of the artifacts. It must not, however,
affect important EEG information at low frequencies. Specifically, it has been shown
that the beta-band (13-30 Hz) and gamma-band (31-100 Hz) frequencies have critical
information for Parkinson’s disease patients [127]. In particular, subthalamic nucleus
DBS has been shown to change the cortical profile of response inhibition in the beta-
band for Parkinson’s disease patients and also to reduce the magnitude of coupling
between beta-phase and gamma-amplitude [53, 57, 128–130].
We demonstrate DBS signals, in time and frequency, using EEG recorded activity
from patients who had been bilaterally implanted with a neurostimulation system;
the data was provided by CNI [122]. Figure 5.1 shows the time-domain plot of a 0.2
second EEG recording segment with both DBS units active, without any processing.
It can be observed that the EEG is masked by the periodic stimulation waveform.
Figure 5.2 shows the Fourier transform (FT) of a longer segment of DBS data; the
spikes can be clearly seen in the frequency domain. Figure 5.3 provides a zoomed
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Figure 5.1: EEG Recording in the Time Domain, With Both DBS Sides Active.
version of Figure 5.2, showing only FT components up to 300 Hz. The spike around
12 Hz, and spikes offset from the DBS harmonics about 12 Hz, can be seen. The
recording is then filtered using a lowpass filter with 90 Hz cut-off frequency; the FT
of the processed signal is shown in Figure 5.4 and its corresponding time domain
signal is shown in Figure 5.5. After filtering, the time domain signal looks more like
EEG, although some large sinusoidal components, due to DBS artifacts, are clearly
present. Figures 5.6 and 5.7 show the EEG signal, in frequency and time respectively,
after it was processed using a Hampel filter (see next section) to suppress the DBS
artifact. The time domain plot can be compared to Figure 5.8 that shows the EEG
of the same data segment but recorded when the DBS was turned off.
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Figure 5.2: Fourier Transform (FT) of the Recording in Figure 5.1.
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Figure 5.5: Recording in Figure 5.4 in the Time Domain.
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Figure 5.3: Zoomed Version of Figure 5.2, for Frequencies Up to 300 Hz.
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Figure 5.6: FT of the Signal in Figure 5.5 after Applying a Hampel Filter.
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Figure 5.4: FT of Recording After Lowpass Filtering with 100 Hz Cut-off Frequency.
5.2 DBS Artifact Suppression
5.2.1 Hampel Filter
One approach for suppressing DBS artifacts is the use of the Hampel filter to
process the EEG recordings [79]. The Hampel filter is a variant on the median filter
that first examines a signal for outliers using a median absolute deviation metric. It
is used to process data sets that have outliers, which is useful for DBS artifact sup-
pression, as the frequency domain of the DBS artifacts consists of narrow spikes [79].
When outliers are found, those points are replaced by the median value of nearby
points. If the Hampel filter is applied in the frequency domain, the narrow spikes can
be removed, leaving behind neural activity unaffected in other frequency bins.
72
Time (s)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Am
pl
itu
de
-25
-20
-15
-10
-5
0
5
10
15
20
25
Figure 5.7: Recording in Figure 5.6 in the Time Domain.
In particular, the outlier detection is performed using the median and median
absolute deviation. If the data sequence {X0, X1, ..., XN−1} is the input to the Hampel
filter, then the test for identifying a point Xk as an outlier is |Xk−X∗| > β B, where
X∗ = median{Xk−L, Xk−L+1, . . . , Xk, . . . , Xk+L−1, Xk+L}, β and L are user-specified
parameters, and B = 1.4286 median{|Xk−L −X∗|, . . . , |Xk −X∗|, . . . , |Xk+L −X∗|}.
The smaller the value of β, the more points are considered as outliers and L varies
the number of points around a candidate outlier when computing the median. Note
that the median filter uses β = 0. If a point is determined to be an outlier, that
point is replaced with the median value X∗. This method is applied to the real and
imaginary parts of the EEG signal in the frequency domain in order to remove the
DBS spectral spikes.
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Algorithm 9 Hampel Filter
Initialization
x[n], n = 0, 1, . . . , N − 1, is the EEG data
Xk, k = 0, 1, . . . , N − 1, is the Fourier transform (FT) of the EEG data
L is user-defined
β is user-defined
for i = 0 : N − 1 do
X∗ = median{Xk−L, Xk−L+1, . . . , Xk, . . . , Xk+L−1, Xk+L}
(The FT sample is not used to compute the median if its index is outside
the {0, 1, . . . , N − 1} range)
B = 1.4826 median{|Xk−L −X∗|, |Xk−L+1 −X∗|, . . . , |Xk −X∗|, . . . ,
|Xk+L−1 −X∗|, |Xk+L −X∗|}
if |Xk −X∗| > β B then
Yk = X
∗
else
Yk = Xk
end if
end for
Output filtered signal {Y0, Y1, . . . , YN−1}
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Figure 5.8: Short Segment of EEG With DBS Turned off.
5.2.2 Time-frequency Filtering
Another method for removing the DBS artifact proposed in literature is the
matched time-frequency filter [80]. This method assumes that the DBS artifact is
composed of a series of pure sinusoids. It thus searches, and then removes, for a
single sinusoid whose frequency, amplitude and phase matches the frequency spike
present in the DBS data [80]. The algorithm iteratively finds the frequency that best
correlates a spike in the EEG signal spectrum. Specifically, first a sinusoid with fre-
quency fi is computed as y[n] = sin(2pifin/fs), n = 0, 1, . . . , N − 1, where fs is the
sampling frequency and N is the number of samples.
At the jth iteration check set of frequencies Fj. For a particular test frequency fi ∈
Fj, we optimize over the available time shifts to apply to the sinusoid in the matched
filter using cross correlation. We check integer time shifts from
⌈
−1
2
fs
fi
⌉
to
⌈
1
2
fs
fi
⌉
. Let
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the EEG signal be x = [x0, x1, ..., xN−1] and the zero padded EEG signal be x[n]. Let
y[n] = sin[2pifin
fs
], and (x ? y)[k] =
∑∞
n=−∞ x[n]y[n + k] since our signals are real. We
then want to find a sinusoid of the form yi[n] = Ai ∗ sin[2pifi(n+∆ki)fs ]. We repeatedly
find the optimal frequency, time shift, and amplitude among the frequencies we test,
then recenter our test around that frequency and check a smaller region in frequency
around it, until we narrow in on a specific sinusoid to subtract out from the EEG
signal.
5.2.3 Empirical Mode Decomposition
The empirical mode decomposition (EMD), also known as the Hilbert-Huang
Transform, can be used to decompose a signal into a fixed number of signal com-
ponents in time [90–92]. The signal components are called intrinsic mode functions
(IMFs) and have unique instantaneous frequencies that are constrained to regions in
frequency that change with time. The IMFs form a complete and nearly orthogonal
basis for the original signal and they satisfy two unique properties: the envelope of
the IMF averages to zero everywhere, and the number of zero crossings and number of
extrema differ by at most one. The EMD algorithm extracts IMFs until the remainder
signal has constant instantaneous frequency. The steps of the EMD, following [92],
are provided in Algorithms 11 and 12. It is based on identifying, and subtracting out,
the fastest oscillation (or highest nonlinearity in the time-frequency plane) present in
the signal, and then iterating the residual signal.
As the EMD approach is data-driven and the IMFs are unique in the time-
frequency plane, we use it to obtain time-frequency features that are different from
those obtained using the matching pursuit decomposition (MPD), as presented in
Chapter 4. The EMD can also be used as an approach to remove the DBS artifact.
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Algorithm 10 Matched Filter Sinusoid Removal
Initialization
x[n], {n = 0, 1, ..., N − 1} is the EEG data
F1 is a course initial set of test frequencies
for j = 1 : J do
for fi ∈ Fj do
y[n] = sin[2pifin
fs
]
∆ki = argmax(x ? y)[k]
{
s.t.
⌈
−1
2
fs
fi
⌉
≤ k ≤
⌈
1
2
fs
fi
⌉}
corrmax = (x ? y)[∆ki]
Ai =
2corrmax
N
end for
iopt = argmaxAi
Aopt = Aiopt
∆kopt = ∆kiopt
fopt = fiopt
Fj+1 is a finer set of frequencies centered around current estimate fopt
end for
y[n] = x[n]− Aopt sin[2pifopt(n+∆kopt)fs ]
Output filtered signal y[n]
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Algorithm 11 Empirical Mode Decomposition
Initialization
x(t) is the input signal
k = 0
x−1(t) = x(t)
while xk−1(t) 6= 0 and xk−1(t) does not have constant instantaneous frequency do
φk(t) = SIFT(xk−1(t))
xk(t) = xk−1(t)− φk(t)
k = k + 1
end while
φk(t) = xk−1(t)
Output set of intrinsic mode functions {φk(t)}
Algorithm 12 SIFT
Initialization
xk−1 is the input data to sift
e(t) 6= 0
while e(t) 6= 0 do
Find U = {(tp, up)} set of all local maxima of xk−1
Find L = {(tp, lp)} set of all local minima of xk−1
u(t) = cubic spline of U
l(t) = cubic spline of L
e(t) = u(t)+l(t)
2
r(t) = r(t)− e(t)
end while
φ(t) = r(t)
Output intrinsic mode function φ(t)
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However, we observed that the IMFs capture much of the brain activity at frequencies
near to the frequencies where the DBS artifact can be found.
5.3 Adaptive Clustering with DBS Artifact Suppression
5.3.1 Description of Data from DBS System
With the ultimate goal being to monitor the DBS automatically to ensure the
treatment is still working well, we look to classify what task a patient is performing
to demonstrate that differences in EEG can be detected and classified algorithmically.
We use 64 channel EEG data from a Parkinson’s disease patient with DBS stimulators
on both sides. Data is available from the patient performing six different tasks, with
each side of the DBS system turned on or off, so that there is data for no DBS, left or
right DBS only or both DBS sides on. The first two tasks are Button Force Left and
Button Force Right, which require pressing a button with a specific force with either
the left or right hand. The third and fourth task are Verbal Fluency tasks, either
Spoken or Written. This involves giving the patient a letter or category, and the
patient gives words verbally or written in the category or that start with the letter.
The fifth task is Reading, reciting the months of the year, and the sixth task is Touch
Pursuit, which is tracing on a touch screen. The tasks are listed in Table 5.1.
5.3.2 DBS Feature Extraction
In Chapter 4, we discussed the use of the MPD with a Gaussian dictionary to
extract features from neurostimulation recordings for use in clustering behavioral
tasks. The features obtained using the MPD are the amplitude, time shift, frequency
shift and scale change of all the Gaussian signals used to expand the data. Another
possible feature set can be obtained using a dictionary of IMFs obtained by expanding
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Class # Name of Task Abbreviation
1 Button Force Left BFL
2 Button Force Right BFR
3 Verbal Fluency Spoken VFS
4 Verbal Fluency Written VFW
5 Reading R
6 Touch Pursuit TP
Table 5.1: Task Information
the data using the EMD. For the EMD based dictionary, we considered 500 time-
domain EEG segments, both for the DBS system turned off and turned on. As IMFs
with the highest nonlinear instantaneous frequency are extracted first, we use the first
IMFs as the feature vectors.
5.3.3 DBS Artifact Suppression
We considered two methods for suppressing the DBS artifacts. The first method is
the Hampel filter, which worked relatively well in removing frequency spikes present in
the data. The second method is based on decomposing the data using the EMD into
specific frequency bands and then removing the IMFs with peak frequencies present
where the DBS artifact is expected. Note that the second method did not provide
very good results as important frequency information near the artifact frequencies
were also suppressed. An example of using the EMD for DBS artifact suppression is
shown in time and frequency, respectively, in Figures 5.9 and 5.10.
When using the Hampel filter to suppress the DBS artifact, we applied it both on
the real and imaginary parts of the frequency domain representation; this provided a
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finely sampled set for clustering. As this approach was computationally time inten-
sive, we first lowpass filtered the data using a 100 Hz cutoff frequency. The Hampel
filter used a 301 point median operation, with β value 4. The lowpass filter applied
was a Chebyshev II of order 14 with 80 dB stopband attenuation and a cutoff of 100
Hz. This was followed by a highpass Butterworth filter of order 4 at 1 Hz to remove
the DC component, which was performed with forward-backward filtering.
For the EMD artifact suppression, the data was similarly lowpass and highpass
filtered before applying the EMD. IMFs with high peaks the frequency spikes at
12 Hz and 60 Hz were first removed, before the remaining IMFs are combined to
obtained the artifact-suppressed signal. Note that for robustness, we applied a slightly
modified version of the EMD as in [91], with some more advanced maxima and minima
detection based on interpolation as well as a sifting stop criteria based on the ratio
of energy in the original signal versus the average of the IMF envelopes.
5.3.4 Adaptive Task Clustering
The aforementioned data processing resulted in six different data sets that were
then used for task clustering. The data set (DS) description, based on the processing,
is given as: MPD Gaussian features and Hampel filtering for artifact suppression (DS
1); MPD Gaussian features and EMD artifact suppression (DS 2); MPD Gaussian
features and no artifact suppression (DS 3); IMF features and Hampel filtering for
artifact suppression (DS 4); IMF features and EMD artifact suppression (DS 5);
and IMF features and no artifact suppression (DS 6). The adaptive clustering was
performed using a Gaussian mixture model (GMM), described in Chapter 4, with
a fixed number of 2 classes. Each class consisted of 15 EEG segments, each of 1
second duration, initiated at the beginning of the patient response. We considered all
pairwise task combinations from Table 5.1, Note that as the initialization of the GMM
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Figure 5.9: EEG Recording with DBS On (Red) and after EMD DBS Suppression
(Blue), Vertical Axis: Amplitude, Horizontal Axis: Time (s).
presented a challenge, we compared the log-likelihood obtained from many different
initializations, with the initial centers placed on all combinations of two points from
the set, and then kept the GMM result with the best log-likelihood.
The clustering results for the six data set combinations are provided in Tables 5.2
and 5.3. Note that we observed a significant difference in the final results based on
the selection of the features used as input to the GMM. The results reported in the
two tables correspond to the selection of the best feature set. For example, when
using the MPD, we did not always select all four Gaussian feature parameters for all
MPD iterations.
The classification results are further demonstrated using two cases. The first
case uses the Button Force Right (BFR) and Verbal Fluency Written (VFW) tasks
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Classes Suppression Method
Class A Class B Gaussian, Hampel Gaussian, EMD Gaussian, None
1 2 63.33% 63.33% 60.00%
1 3 60.00% 73.33% 70.00%
1 4 66.67% 63.33% 63.33%
1 5 93.33% 83.33% 90.00%
1 6 56.67% 63.33% 60.00%
2 3 86.67% 63.33% 66.67%
2 4 80.00% 63.33% 73.33%
2 5 100.00% 93.33% 86.67%
2 6 60.00% 56.67% 63.33%
3 4 60.00% 60.00% 83.33%
3 5 70.00% 73.33% 80.00%
3 6 90.00% 73.33% 63.33%
4 5 66.67% 76.67% 90.00%
4 6 86.67% 60.00% 60.00%
5 6 96.67% 76.67% 86.67%
Ave. 75.78% 69.56% 73.11%
Table 5.2: Classification Results Using a Gaussian MPD Dictionary and Various DBS
Suppression Methods, Best Case Features.
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Classes Suppression Method
Class A Class B IMF, Hampel IMF, EMD IMF, None
1 2 63.33% 60.00% 66.67%
1 3 73.33% 70.00% 86.67%
1 4 76.67% 66.67% 83.33%
1 5 93.33% 90.00% 93.33%
1 6 56.67% 60.00% 70.00%
2 3 80.00% 80.00% 80.00%
2 4 70.00% 66.67% 63.33%
2 5 93.33% 90.00% 90.00%
2 6 63.33% 60.00% 60.00%
3 4 80.00% 66.67% 63.33%
3 5 66.67% 73.33% 73.33%
3 6 80.00% 66.67% 73.33%
4 5 80.00% 90.00% 93.33%
4 6 70.00% 70.00% 66.67%
5 6 80.00% 93.33% 93.33%
Ave. 75.11% 73.56% 77.11%
Table 5.3: Classification Results with IMF Dictionary and Various DBS Suppression
Methods, Best Case Features.
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Figure 5.10: The Fourier Transform of the Signals in Figure 5.9, Vertical Axis: Mag-
nitude Spectrum, Horizontal Axis: Frequency (Hz).
with the data processed using MPD Gaussian features and Hampel filtering artifact
suppression (DS 1). Figures 5.11 and 5.12 demonstrate the GMM clusterering for the
VFW task and BFR task, respectively, obtained using the magnitude and frequency
shift MPD Gaussian features. In these figures, the BFR task features for each data
point to classify are marked with white Os; white Xs are used for the VFW data
points. The decision region used for clustering is shown in Figure 5.13. We can see
the five misclassifications for BFR (two on top of each other) and one misclassification
for VFW, resulting in an overall correct classification rate of 80%. The second case
uses the Reading (R) task and the Touch Pursuit (TP) task with the data processed
using EMD IMF features and Hampel filtering artifact suppression (DS 4). The three
corresponding plots are provides in Figures 5.14, 5.15, and 5.16. The R task points
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are marked with white Xs and the TP task points are marked with white Os. The
best feature set selected consisted of the amplitudes of the first two IMF components.
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Figure 5.11: Gaussian Cluster for VFW Task.
5.4 Clustering Using Disease-Matched Features
As discussed at the beginning of this chapter, studies have shown that the beta
frequency band ranging from 13 to 30 Hz and the gamma frequency band ranging
from 31 to 100 Hz from EEG and LFP recordings provide critical information on
the pathology of Parkinson’s disease as well as on task performance [16, 28, 57–
67, 127]. Tasks involving movement and word recognition have been shown to change
the activity in the beta and gamma bands, as well as other bands, in characteristic
ways that could be useful for classification. Using this prior information, we now
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Figure 5.12: Gaussian Cluster for BFR Task.
select EEG recording features that concentrate in these specific frequency bands in
order to increase classification performance.
We thus processed EEG recordings to consider five different cases, such that the
resulting signals only contain components in specific frequency bands. All the record-
ings correspond to two behavioral tasks: Verbal Fluency Written (VFW) and Reading
(R). In Case 1, the processing involved suppressing the DBS artifact near 12 Hz (when
the DBS is turned on) and the power line artifact at 60 Hz using the time-frequency
filtering approach. Case 2 consisted of frequencies in the delta band (frequencies be-
low 4 Hz), beta band and gamma band, resulting from a 100 Hz lowpass filter and
4-13 Hz bandstop filter; Case 3 consisted of frequencies in the beta and gamma bands,
resulting from a 100 Hz lowpass filter and a 13 Hz highpass filter; Case 4 consisted
of frequencies in the beta band only, resulting from a 13-30 Hz bandpass filter; and
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Figure 5.13: GMM Decision Boundary.
Case 5 consisted of frequencies only in the gamma band, resulting from a 30-100 Hz
bandpass filter. Note that all filters used a 40th order Butterworth with half-power
at the designated frequencies.
For this classification, we selected 15 EEG recordings from each task from the
Cp2 electrode. This specific electrode was selected in order to minimize the effects
of muscle and speaking artifacts in the EEG recordings. The Cp2 location is slightly
back and to the right from the top of the head, which is far from the physical locations
of the tongue tip and neck. The data is referenced to the mastoid, setting the EEG
reference to the corner of the jaw to further reduce muscle effects. Also, half of the
data segment was taken from before the patient starts to move, so only half of each
signal is possibly corrupted by muscle and speaking artifacts.
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Figure 5.14: Gaussian Cluster for R Task.
For the clustering, we first obtained MPD time-frequency features and used them
with a GMM with two classes representing two specific tasks. We considered clas-
sification results by varying the number of MPD iterations, for a maximum of 60
iterations. We provide results for the number of iterations that resulted in the high-
est overall correct classification rate; past that number, noise present in the data was
decomposed and thus reduced classification performance. The GMM was initialized
by using 100 replicates of the k-means++ initialization, using k-means to obtain a
starting guess for the clusters.
When the DBS was turned on, we obtained the highest classification performance
for Case 5 (only gamma band). The rate of correct classification remains between
80% and 83% (using 28 to 34 MPD iterations) before dropping off past 73%. When
the DBS is turned off, Case 2 resulted in the highest classification performance (76%
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Figure 5.15: Gaussian Cluster for TP Task.
to 80% using 21 to 24 MPD iterations. The confusion matrices for Case 5 and DBS
turned on are shown in Tables 5.4 and 5.5 (corresponding to range in performance).
The confusion matrices for Case 2 and DBS turned off are shown in Tables 5.6 and 5.7.
In order to ensure that the classification results were obtained using representative
information, we consider the signal energy captured by the MPD features. The follow-
ing figures show the 95% confidence interval of the MPD residual energy, normalized
to the energy of the initial signal, for the 15 signals in each class. Figure 5.17 shows
the residual energy curve for Case 5 with DBS turned on, and Figure 5.18 shows the
residual energy curve for Case 2 with the DBS turned off. As another example, Fig-
ure 5.19 shows the residual energy for Case 4 (only beta band) with the DBS turned
on. As compared to Case 5 in Figure 5.17, even most of the signal is decomposed
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Figure 5.16: GMM Decision Boundary.
after a few iterations, the resulting features did not provide useful information for
classification.
Class VFW Class R
True Class VFW 86.7% 13.3%
True Class R 20% 80%
Table 5.4: Confusion Matrix, Case 5 with DBS Turned on.
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(a) Class VFW
(b) Class R
Figure 5.17: Residual Energy (vertical axis) Versus Number of Iterations (horizontal
axis), Case 5 with DBS Turned on: Classes (a) VFW and (b) R.
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(a) Class VFW
(b) Class R
Figure 5.18: Residual Energy (vertical axis) Versus Number of Iterations (horizontal
axis), Case 2 with DBS Turned off: Classes (a) VFW and (b) R.
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(a) Class VFW
(b) Class R
Figure 5.19: Residual Energy (vertical axis) Versus Number of Iterations (horizontal
axis), Case 4 with DBS Turned on: Classes (a) VFW and (b) R.
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Class VFW Class R
True Class VFW 80% 20%
True Class R 20% 80%
Table 5.5: Confusion Matrix, Case 5 with DBS Turned on.
Class VFW Class R
True Class VFW 93.3% 6.7%
True Class R 33.3% 66.7%
Table 5.6: Confusion Matrix, Case 2 with DBS Turned off.
Class VFW Class R
True Class VFW 86.7% 13.3%
True Class R 33.3% 66.7%
Table 5.7: Confusion Matrix, Case 2 with DBS Turned off.
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Chapter 6
CONCLUSIONS AND FUTURE WORK
6.1 Conclusions
Biomedical and biological signals provide very powerful information in medicine.
We propose advanced signal processing methods that allow for the detection and
treatment of some neurological diseases. These include methods in neuroscience that
perform artifact suppression to track the location of brain activity and classify be-
havioral patient tasks for the purpose of improving the currently used deep brain
stimulation treatment for Parkinson’s disease. They also include methods in immune
response that use time-frequency methods to process microarray data to determine
what protein sequence from a possible pathogen generated antibodies.
6.1.1 Neural Stimulation and Activity Tracking
We use object tracking algorithms, originally based on radar applications, which
account for spurious measurements to track the sources of neural activity in the
brain. Independent component analysis (ICA) is used to separate the measurements
from neural current sources and artifacts such as eye blinks and movements, the
power line, muscle movements, heartbeats, and electrode popping. Our proposed
method, the probabilistic data association filter, tracks neural sources, suppressing
measurements that appear to originate from artifacts. This is done by looking at the
power spectrum of the ICA separated measurements to discriminate neural activity
from artifact. The source location error metric falls below 8 mm in an 85 mm radius
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head region. Further methods of neural source tracking and artifact suppression have
been explored by other members of the research group in [115, 131].
We also use the matching pursuit decomposition (MPD) to extract features for
classification of electroencephalogram (EEG) recordings in Parkinson’s disease pa-
tients for the purpose of assessing their deep brain stimulation (DBS) treatment.
We look to detect differences in the brain rhythm as treatment progresses to see if
the stimulation parameters need adjusting. To that end, we look to classify EEG
recordings when the patient is performing different tasks to see if any changes in the
patient’s symptoms can be detected. The classifier is based on the Gaussian mixture
model (GMM), an unsupervised clustering approach that does not need training. The
features extracted by MPD describe the time-frequency characteristics of the EEG
signal. We are sometimes able to achieve classification using particular features from
just the first few atoms, but this likely will not provide a stable classification as it
uses very little information about the signal. Thus, we perform classification using
many MPD atoms that contain most of the energy in the signal. We are able to get
83% classification between a mental recitation task and writing task using about 30
MPD atoms comprising 80% of the energy in the signal within the relevant frequency
bands examined. We chose the frequency bands to match up to the bands where brain
activity has been found to occur in cognitive and behavioral tasks in the literature.
When the DBS system is on, there is an artifact generated that can be suppressed
with some lowpass filtering to remove the high frequency components of the artifact,
leaving behind high spectral peaks that can be attenuated using with Hampel filtering
in the frequency domain or a time-frequency matched filter in the time domain.
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6.1.2 Pathogen Detection
Some additional work, separate from the neuroscience work in this thesis, is pre-
sented in Appendix A on pathogen detection based on peptide microarrays [121]. By
using time-frequency matching pursuit methods, we were able to identify significant
subsequences of monoclonal antibodies within peptide microarray data by determin-
ing which subsequences raised the fluorescence response higher for one monoclonal
antibody than the others. Some antibodies only had partial matches, though this is
consistent with antibodies having a specific active region that is not the full pathogen
protein. The ability to identify protein sequences on a microarray that draw a strong
antibody response can be used for pathogen identification by determining what pro-
tein sequences the antibodies respond to, and matching these up to pathogen proteins.
6.2 Future Work
For EEG source tracking, a metric for discriminating between neural activity and
artifacts, more aligned with the physiological differences between neural sources and
artifacts than a general frequency content energy trend, is important. It is difficult
to construct synthetic data that both follows the model and is independent so that
ICA can be applied, leading to ICA making errors in separation that challenge the
tracking algorithm. Work towards this end has been undertaken by other members
of the research group in [115, 131]. We will work toward suppressing more types of
artifacts, as well as looking at additional experimental EEG data sets. We are also
considering more involved models for the head, including patient specific magnetic
resonance imaging (MRI) scan models.
The next step for the deep brain stimulation research is working with more data.
The Colorado Neurological Institute (CNI) is reducing the complexity of the tasks
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being performed, as it is difficult to extract information for the many tasks in our
current data set, especially with the complexity of the tasks. Use of the Dirichlet
process GMM (DP-GMM) instead of the GMM, so that the number of tasks does
not need to be specified beforehand, is also important. This is because the ability
of the DP-GMM to determine the number of classes allows for the addition of new
data to past data. If the patient’s brain activity has changed significantly since pre-
vious measurements, the DP-GMM will place the new activity in a new class instead
of the already established class, allowing for further monitoring of the neurological
treatment. Additional features provided to the DP-GMM would also increase its
monitoring potential, including location and orientation features of the neural source
activity. Incorporating the artifact suppression available while tracking could be used
to help reduce possible muscle artifacts during tasks even further than the algorithms
considered in this work. It is important to obtain measurements from more patients
to generalize these results and examine the patient specificity of the time-frequency
features. With more patients, the DBS artifact could be better characterized for
suppression. Another idea is to improve the feature selection using beta distribu-
tion fitting and measuring the difference between the distributions, similarly to the
method discussed in [97].
For pathogen detection, early results for identifying monoclonal antibodies on the
peptide arrays are promising. New data with many monoclonals tested at the same
time to minimize processing differences would be the next step, followed by testing
immune responses of people with known diseases. Multiple patients with the same
disease or monoclonal antibody target should be tested for patient specificity, as not
all immune systems are the same. For patients with a known disease, estimated epi-
topes can be compared with protein databases to find proteins that drew the response.
Finding multiple epitopes that map to pathogen proteins is strong evidence of a pa-
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tient having a specific disease. The MPD algorithm can be improved by incorporating
information about common substitutions and properties such as the hydrophobicity
of amino acids. Matching could also be performed with three-dimensional protein
information by mapping onto multidimensional Gaussians.
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APPENDIX A
BIOSEQUENCE TIME-FREQUENCY PROCESSING: PATHOGEN
DETECTION AND IDENTIFICATION
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A.1 Description of Work in Appendix
This appendix contains a published chapter, referenced as [121] above, in the
references section for the main chapters. This work is part of collaborative research
on biological signal processing, and it is not related to the biomedical signal processing
work presented in Chapters 1-5.
A.2 Abstract
Diagnostic information obtained from antibodies binding to random peptide se-
quences is now feasible using immunosignaturing, a recently developed microarray
technology. The success of this technology is highly dependent upon the use of ad-
vanced algorithms to analyze the random sequence peptide arrays and to process
variations in antibody profiles to discriminate between pathogens. This work presents
the use of time-frequency signal processing methods for immunosignaturing. In par-
ticular, highly-localized waveforms and their parameters are used to uniquely map
random peptide sequences and their properties in the time-frequency plane. Ad-
vanced time-frequency signal processing techniques are then applied for estimating
antigenic determinants or epitope candidates for detecting and identifying potential
pathogens.
A.3 Introduction
A.3.1 Signal Processing of Biological Sequences and Challenges
The area of bioinformatics is mainly involved with the management of biological
information using computer technology and statistics. Signal processing for molec-
ular biology, on the other hand, encompasses the development of algorithms and
methodologies for extracting, processing and interpreting information from biological
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sequences [1-6]. Intelligent use of signal processing algorithms can provide invaluable
insight into the structure, functioning and evolution of biological systems. For exam-
ple, complex assays to determine functional activities of analytes or peptide chips to
manifest key residues for protein binding can provide a wealth of information on un-
derlying biological systems. However, in each of these cases, appropriately designed
processing is required to robustly extract the most relevant information. Images of
array fluorescence are enhanced to improve the estimation of gene reactivity, while
gene expression classification performance is increased by including biological and
experimental variability in the algorithm design [4].
Genomics and proteomics, in general terms, study the functions and structures
of genomes and proteomes, respectively. Genomes, which are genetic material of
organisms encoded in deoxyribonucleic acid (DNA) or ribonucleic acid (RNA), and
proteomes, which are expressed proteins in given organisms, provide discrete infor-
mation, represented in sequences of unique elements [7,8]. More specifically, DNA
are bio-molecules that are represented as letter sequences of precise orderings of four
nucleobases; the different orderings correspond to patterns that influence the forma-
tion and development of different organisms. Similarly, proteins are bio-molecules
represented as sequences of unique orderings of twenty linked amino acids, with each
amino acid represented by a letter of the alphabet. DNA and protein sequence analysis
requires significant processing of the discrete gene orderings in order to identify in-
trinsic common features or find gene variations such as mutations [9,10]. One genome
analysis application is gene sequence periodicity as regions of genetic repetition have
been shown to correlate with functionally important genes [11,12]. Gene periodic-
ity has been analyzed using spectral methods [13-16]; such methods have also been
used to estimate variations in base pair frequencies between organisms as they can
indicate phylogenic origin from the species genome. Time-frequency signal process-
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ing methods such as wavelet transforms have also been used in gene sequencing such
as to characterize long range correlations or identify irregularities in DNA sequences
[14,17,18].
Signal processing methods have also been used for sequence alignment, or arrang-
ing sequences to identify regions of similarity due to functional, structural, or evolu-
tionary relationships between the sequences [19,20]. As thousands of organisms have
been sequenced completely, and many more have been partially sequenced, search-
ing for these similarities requires a vast number of computations. There are many
algorithms designed to perform these searches including dynamic programming algo-
rithms such as Smith-Waterman and BLAST, correlation based methods, Bayesian
approaches, and time-frequency (TF) based methods [10, 21-28]. Computational
alignment tools based on dynamic programming such as the Smith-Waterman algo-
rithm is guaranteed to find all similarity matches, but it runs slowly [21]. Other tools,
such as BLAST [22,23], are widely made available for database similarity searching as
they were developed to provide a fast approach of approximating the complete align-
ment found by dynamic programming algorithms. BLAST runs very quickly, around
an order of magnitude faster than the complete alignment algorithms, and finds most
significant alignments under most circumstances. However, it tends to miss align-
ments for queries with repetitive segments. Correlation based methods map DNA or
amino acid sequences to real or complex numbered sequences and use sequence cor-
relation to achieve a match in similarity [26]. The algorithm can be implemented fast
using the fast Fourier transform; however, errors increase when aligning sequences of
longer lengths. We have recently developed a TF based method that first uniquely
maps sequences to highly-localized Gaussian waveforms in the TF plane, and then
uses the matching pursuit decomposition (MPD) algorithm to perform alignment [28-
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30]. The alignment approach is compared to other approaches and shown to perform
well with repetitive segments in real time without pre-processing.
In addition to gene sequencing, microarray analysis has also played a significant
role in the extraction and interpretation of genomic information. Microarrays can
provide measurements of expression levels of large numbers of genes. For example,
peptide microarrays have been used to study binding properties and functionality
of different types of protein-protein interactions and provide insight into specific
pathogens [31-35]. Peptide microarrays are a relative new application for biologi-
cal signal processing. The technology to create assays using single peptide chains
has been around for a while in the form of the enzyme linked immunosorbent assay
(ELISA) [36]. In recent years, as the cost of printing many peptide clusters onto a
single substrate has been dropping, tens or hundreds of thousands of peptide clusters
can be reasonably printed on a single array. In addition to be able to construct large
scale peptide arrays to detect specific diseases, another important aspect is the robust
interpretation and analysis of the extracted data in order to establish relationships
between peptide sequences and binding strengths. Some recent analysis approaches
include support vector machine (SVM) modeling methods [37], computational align-
ment approaches [38], and statistical tools such as t-test and analysis of variance
linear regression [39-41].
A.3.2 Signal Processing Challenges: Random-Sequence Microarrays
The recently developed immunosignaturing technology uses microarrays with ran-
dom-sequence peptides to associate antibodies to a pathogen or infectious agent, in a
patient’s blood sample [32, 42-49]. The immunosignatures can potentially provide pre-
symptomatic diagnosis for infectious diseases [35,44,48]. The large number of peptide
sequences on each microarray, and the attraction of the ability to diagnose as many
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pathological ailments as possible, renders a challenging problem in signal processing.
This is further complicated by the fact that, in general, training data is not available.
Current processing methods include statistical tests [45] and supervised classification
and learning methods such as support vector machines [43,48]. Recently, we have de-
veloped adaptive learning methodologies for unsupervised clustering integrated with
immunosignature feature extraction approaches [50-52].
This work develops new algorithms for analyzing and processing random peptide
sequences in the TF plane in order to recognize pathogens from variations in antibody
profiles without any prior information. Given immunosignaturing random-sequence
peptide microarray data for an individual, the task is to detect and identify the
binding sites of antibodies for target antigens. These binding sites, or linear epitopes,
are short continuous sub-sequences of the peptide sequence that correspond to the part
of an antigen that is recognized by the antibodies [32,53,54]. Detecting which peptides
bind to which antibodies by identifying the corresponding antibody sub-sequence
binding sites using immunosignaturing data is very useful as one dataset contains
can localized information on multiple pathogens [52]. As a result, the detection
and identification algorithms can be used to characterize antibody specificity for the
molecular recognition of the immune system or for deciphering molecular mechanisms
for various diseases.
A.4 Random Sequence Peptide Microarrays
Immunosignaturing is a microarray-based technology that uses random peptide
sequences to provide a comprehensive profiling of a person’s antibodies [42,44,55]. It
has been shown that a person’s antibody profile, about 109 different antibodies in the
blood at a given time, is a sensitive indicator of the person’s health status. Part of the
body’s response to a foreign pathogen is to create antibodies which identify and aid in
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the destruction of that pathogen. Pathogen detection and determination is possible
due to a uniquely identifying amino acid sequence on its exterior called an antigen.
The antibodies created in response to the pathogen are designed to only bind to that
specific antigen sequence, or one that is very similar. As the antibodies amplify when
the host is exposed to an infectious agent, the amplified antibody response enables
monitoring a disease upon infectivity. Rather than trying to identify an antibody by
designing a microarray specific to a pathogen, the concept of immunosignaturing is
to identify an entire immune response. This is achieved by printing an array with
many different random peptides, so that small subsets of peptide sequences are similar
enough to antigen sequences of specific pathogen antibodies to bind to them.
The immunosignaturing technology has been developed by the director and re-
searchers of the Center for Innovations in Medicine (CIM) at the Biodesign Institute
at Arizona State University [56]. In particular, the random-peptide microarray data
used for algorithm demonstration in this work was provided by CIM. Information
on the technology, such as a description of the equipment, arrays, and a technolog-
ical overview, can be found at http://www.immunosignature.com. The immuno-
signaturing technology currently employs slides spotted with peptides, resulting in
microarrays with 330,000 peptide sequences (330k chip). The peptides sequences are
20 amino acids long and a random number generator is used to generate the specific
peptide sequences. Other than cysteine that is used as the C-terminal amino acid,
all natural amino acids are included in the peptide sequence generation. As a result,
the peptide sequences are random and not related to any naturally occurring peptide
sequence; however, the sequence on each spot on the slide is known. This ensures
that the peptide array is not designed to monitor one specific disease or a set of dis-
eases. Array peptides are designed to fluoresce in proportion to an antibody binding
strength when light of a specific frequency is shined on them. Peptides with attached
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antibodies are expected to fluoresce more brightly than the those not related to the
antigen. Multiple identical peptides are printed within a predefined circular area on
the array; after the sample is given sufficient time to bind, the array is washed and
then illuminated. An image of the fluorescing array is taken, and the median flu-
orescence value of the pixels in each circular area is calculated and recorded. The
resulting data used for analysis is the peptide sequence of amino acids and its cor-
responding median fluorescence value at each array spot. Using the data from the
whole array, the problem is to detect the highly fluorescing peptides and identify the
corresponding underlying pathogens.
This is not a simple detection and identification problem; processing can be com-
plicated by the fact that there are additional macromolecules in blood samples that
can also bind to peptides due to hydrogen bonding, electrostatic interactions and van
der Waals forces [57]. The concept of adding a large number of random peptides on
the array is novel as more pathogens can be detected on a single patient. However, the
large number of sequences to process also increases the number of sequences that are
close in structure to more than one pathogen’s antigen. Antibodies bind with enough
variability that trends across multiple peptides must be used. However, a significant
difficulty in finding these trends is that only a sub-sequence of the peptide which
binds to the antibody is responsible for the binding, and within that sub-sequence
there can be one or two peptides which have little or no effect on the binding strength.
Determining which peptide sub-sequences are responsible for that binding must be
determined using multiple peptides with similar sub-sequences [44,45].
A.5 Time-Frequency Processing of Peptide Sequences
The novel signal processing algorithms presented in this work aim to improve
pathogen detection and identification performance when using immunosignaturing
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random peptide sequences. Toward this end, advanced signal processing methodolo-
gies are exploited to first map amino acid sequences to unique and highly TF localized
waveforms and then use matched TF representations to identify specific peptide sub-
sequences.
A.5.1 Mapping Peptide Sequences to Time-frequency Waveforms
The biosequence-to-waveform mapping considered must provide a unique wave-
form in the TF plane for each peptide sequence. When deciding on appropriate
waveforms to use in the mapping, the waveform parameters and properties must be
selected to ensure uniqueness in peptide representation and robustness in matched
correlation-based processing, respectively. Following the scheme we adopted in [28].
Gaussian waveforms are selected for mapping as they are the most localized waveforms
in both time and frequency [58]. A basic Gaussian waveform g(t) is first obtained as
g(t) =
1
(piσ2)1/4
e−t
2/(2σ2), t ∈ (−Tg/2, Tg/2) , (A.1)
with unit energy and centered at the origin in the TF plane. The parameter σ2
affects the waveform’s duration Tg and spread in frequency. When this waveform is
time-shifted by nT and frequency-shifted by kF ,
gn,k(t) = g(t− nT ) ej2pikF (t−nT ), t ∈ (nT − Tg/2, nT + Tg/2) (A.2)
for integer n and k, the resulting Gaussian waveform is highly-localized at the TF
point (nT, kF ). Note that the time shift step T > Tg and the frequency shift step F ,
and thus σ2 in (A.1), are chosen to ensure that the spacing between the time-freqency
shifted Gaussian waveforms is compact and the waveforms are non-overlapping.
For the biosequence-to-waveform mapping, the time shift and frequency shift are
used to uniquely represent properties of the amino acids in the peptide sequence. Each
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of the twenty possible different amino acids in a peptide sequence can be characterized
by a unique one-letter code, as shown in the first two columns of Table A.1. For the
mapping, twenty possible frequency shifts kF , k= 1, . . . , 20, in Equation (A.2) are
used to represent the twenty different types of amino acids, as shown in the third
column of Table A.1. The position of the amino acid in the peptide sequence is
mapped to the time shift parameter nT in (A.2). Considering a peptide sequence
of length N = 20 amino acids, N time shifts are needed to represent the peptide
sequence; the number of time shifts is the same as the length of the sequence. A TF
representation of all possible Gaussian waveforms needed to map peptide sequences
of length N = 10 amino acids is demonstrated in Figure A.1(a).
Considering a peptide sequence p[n] =αn, n= 1, . . . , N , of N amino acids α1 α2
. . . αN−1 αN , the mapping function f [{αn}] = k is used to identify the one-letter code
representing the amino acid αn and its corresponding frequency shift kF from Table
A.1. Note that the range of the mapping function f [{·}] is the set of positive integers,
k= 1, . . . , 20; the domain of the function consists of the one-letter codes from Table
A.1. Using this mapping function, the resulting waveform that is used to map peptide
sequence p[n] is given by
gpept(t) =
N∑
n=1
gn,f [{αn}](t; p) =
N∑
n=1
g(t− nT ) ej2pif [{αn}]F (t−nT ) . (A.3)
The duration of the overall waveform gpept(t) N T + Tg.
An example of a peptide sequence of length N = 10 is given by ARVHHKHVVE; its
corresponding TF representation is shown in Figure A.1(b). The waveform in (A.3)
used to map this sequence is a linear combination of 10 TF-shifted Gaussian wave-
forms. Ten unique time shifts are used in the mapping; the frequency shifts are not
unique since the same amino acid can occur multiple times in a peptide sequence. It
follows that there is only one Gaussian waveform at each time shift but (possibly)
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Amino One-letter Mapped
Acid Code Frequency
Alanine A 20F
Arginine R 19F
Asparagine N 18F
Aspartic acid D 17F
Cysteine C 16F
Glutamic acid E 15F
Glutamine Q 14F
Glycine G 13F
Histidine H 12F
Isoleucine I 11F
Leucine L 10F
Lysine K 9F
Methionine M 8F
Phenylalanine F 7F
Proline P 6F
Serine S 5F
Threonine T 4F
Tryptophan W 3F
Tyrosine Y 2F
Valine V F
Table A.1: Frequency Mapping of Twenty Amino Acids.
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Figure A.1: Time-Frequency Representation of Gaussian Mapped Waveforms (a)
for Peptide Sequences of 10 Amino Acids in Length; (b) for Amino Acid Sequence
ARVHHKHVVE; (c) for the Same Sequence with Any Substitution in the 4th Amino Acid
position, ARV-HKHVVE; (d) for the Same Sequence with Any Substitutions in the 4th
and 5th Amino Acid Positions, ARV--KHVVE.
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multiple Gaussian waveforms at different frequency shifts; a peptide sequences does
not necessarily consist of all possible 20 amino acids. For the example of the length
10 peptide sequence ARVHHKHVVE in Figure A.1(b), and using the mapping in (A.3)
and the information from Table A.1, α1 α2 α3 α4 α5 α6 α7 α8 α9 α10 = A R V H H K H V V E
and f [{α1}]=20, f [{α2}]=19, f [{α3}]=f [{α8}]=f [{α9}]=1,
f [{α4}]=f [{α5}]=f [{α7}]=12, f [{α6}]=9, and f [{α10}]= 15. Specifically, the three
histidine (H) amino acids in the sequence are represented in Figure A.1(b) by the
three Gaussian waveforms at the same frequency shift 12F and different time shifts,
4T , 5T , and 7T , respectively.
A.5.2 Processing Waveforms of Mapped Peptide Sequences
The peptide sequence mapping in Equation (A.3) results in a linear combination
of non-overlapping Gaussian signals in the TF plane. A linear epitope or small con-
tinuous segment of the peptide sequence can be used as an antigenic determinant to
a pathogen’s antibodies. Identifying epitopes can be seen as searching for potential
sub-sequences that are either repeated very often or are frequently repeated with
significant binding strength on the microarray. After waveform mapping, the detec-
tion and identification problem of epitopes or repeated sub-sequences over a large
number of peptide sequences on a microarray becomes an estimation problem of the
matched Gaussian waveform parameters representing the amino acids in the epitope.
As a result, epitope waveform parameter (EpiWP) estimation can be performed using
matched signal expansion algorithms, such as the MPD [59]. Specifically, identifying
repetitions in the sequences maps to estimating matched parameters in the waveforms.
The MPD is an iterative algorithm that can decompose a waveform into a linear
combination of weighted dictionary waveforms. The dictionary waveforms are formed
by TF shifting a basis waveform that is selected to be well-matched to the analysis
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waveform. The MPD can be applied to the EpiWP estimation problem using the
Gaussian waveform in (A.1) as the dictionary basis signal. Then the epitope mapped
waveform to be decomposed and the MPD dictionary waveforms are in the form of
A.3. In particular, mapped epitope candidate (MEpiC) waveforms are formed by
considering possible amino acid sub-sequences from the peptide sequences. Using the
MPD to decompose an MEpiC waveform results in a small set of MPD features that
uniquely characterize the MEpiC waveforms; those features are then searched over
all mapped peptide sequences on the microarray. A suitably derived metric for the
number of peptide sequences identified to have the matched MEpiC waveform can
then be used to indicate whether the epitope candidate could be related to an epitope
of the antibodies of a particular pathogen.
Assuming an epitope of length L, the MEpiC waveform gepit(t) is given by Equa-
tion (A.3) with N replaced by L, the length of the epitope. 1 At each iteration,
the MPD identifies a single TF shifted Gaussian waveform from the MEpiC wave-
form. This is accomplished by finding the best match between each of the mapped
amino acids forming the MEpiC waveform gepit(t) and possible mapped amino acids
gpept,n,f [{αn}](t) forming the peptide waveform. The MPD requires L iterations to find
a match of the MEpiC waveform within the mapped peptide waveforms. At the start
of the MPD algorithm, the best matched dictionary waveform between the MEpiC
waveform and the mapped peptide amino acid waveforms is obtained as
g
(1)
n1,f [{αn1}](t) = argmaxn
∫
gepit(t) gpept,n,f [{αn}](t) dt , (A.4)
where g
(1)
n1,f [{αn1}](t) is a Gaussian waveform centered at time shift n1 T and frequency
shift f [{αn1}]F , and n1 is the value of n that yields the maximum correlation value in
1Note that the same notation, αn, is used to denote amino acids in peptide sequences and amino
acids in epitope sequences, which are sub-sequences of the peptide sequences. The specific type of
sequence, peptide or epitope, is differentiated, when needed, using the notation gpept(t) and gepit(t),
respectively.
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(A.4) after the first iteration. At the `th iteration, `= 2, . . . , L, the residual MEpiC
waveform is given by
r
(`)
epit(t) = gepit(t)−
`−1∑
m=1
g
(m)
nm,f [{αnm}](t) .
The best matched dictionary waveform between the residual MEpiC waveform and
the mapped peptide waveform is given by
g
(`)
n`,f [{αn`}](t) = argmaxn
∫
r
(`)
epit(t) gpept,n,f [{αn}](t) dt . (A.5)
The discrete value n` is the sequence position index n that yields the maximum
correlation value in (A.5) at the `th iteration. Note that there are no correlation
coefficients to consider in the expansion as the Gaussian waveforms are normalized to
have unit energy. The algorithm iteratively continues until L iterations, when there
are no more matches left between the MEpiC waveform and the mapped peptide
waveform. After L iterations, the decomposed mapped peptide waveform is given by
g˜(t) =
L∑
`=1
g
(`)
n`,f [{αn`}](t) + r
(L+1)
epit (t) . (A.6)
The matched MEpiC waveform components are given by the summation term in the
right-hand side of Equation (A.6); the unmatched ones are in the residue r
(L+1)
epit (t).
The Gaussian waveform matching can then be used to obtain an epitope identification
metric in terms of the energy of the decomposed Gaussian waveform components. The
metric, for a candidate epitope, is given by
sepit =
∫ ∣∣∣ L∑
`=1
g
(`)
n`,f [{αn`}](t)
∣∣∣2dt (A.7)
Note that each mismatch between the MEpiC waveform and the matched peptide
waveform decreases the matching metric by one as the energy of the decomposed
term also decreases by one.
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The MPD algorithm can also be used for matching MEpiC waveforms which model
biologically relevant substitutions. The matching is performed using the same MPD
algorithm with a modification to the MEpiC waveforms. This is demonstrated in
Figures A.1(c) and A.1(d) for the length 10 sequence ARVHHKHVVE represented in the
TF plane in Figure A.1(b). In Figure A.1(c), the same sequence is considered but
with a substitution allowed by any amino acid in the 4th position. The effect on
the MEpiC waveform is to include a Gaussian waveform at each frequency shift at
the 4th position (or time shift); this implies that any mapped peptide waveform is
matched to the MEpiC waveform at the 4th time shift. The same sequence but with
two substitutions in the 4th and 5th amino acid positions is demonstrated in Figure
A.1(d).
A.6 Epitope Waveform Parameter Estimation
The epitope waveform parameter estimation algorithm consists of three main
steps. During the first step, the candidate epitope and peptide amino acid sequences
are mapped to Gaussian waveforms, following the discussion in Section A.5.1. Dur-
ing the second step, the peptide sequences are down selected by first pre-processing
the peptide sequences, and then applying some selection criteria and thresholding;
the reduced number of peptides after selection are the ones most likely to have been
bound to by antibodies. The third step performs the epitope waveform parameter
estimation using the MPD-based matching approach discussed in Section A.5.2. The
steps are summarized in Figure A.2.
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Figure A.2: Block Diagram Depicting the Algorithm for Epitope Waveform Parameter
(EpiWP) Estimation.
A.6.1 Peptide Selection Method
Pre-processing. Peptide array data from individual disease samples are median
normalized to account for the different binding times required. Some samples require
longer time to bind fully to the array before the sample solution is rinsed off.
Ranking Based on Peptide Selection Criteria. As the number of microar-
ray random peptide sequences, Mp, is very large for efficient processing, the peptide
sequences need to be ranked according to some peptide selection criteria, and then
a selected smaller number of peptides, Ms, can be used as input to the EpiWP es-
timation algorithm. One peptide selection criterion is based on fluorescent intensity
levels; the peptides with the highest fluorescent intensity levels, or levels above some
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background fluorescent intensity threshold, are selected as they correspond to the
peptides that bind to the antibodies. For some datasets, it is possible for antibodies
to bind weakly to peptides that do not have the highest fluorescence values. As a
result, a different peptide selection criterion is needed for these datasets. The cri-
terion is based on finding correlations or dependence between multiple datasets; the
fluorescent intensity levels from multiple datasets can be compared in order to select
peptides with high fluorescence values relative to the comparison data.
The second peptide selection criterion is applied using Pearson’s correlation co-
efficient between the fluorescent intensity levels of the array peptides and a binary
indicator vector. Assuming D microarray datasets for comparison, with Mp peptides
per microarray dataset, the correlation coefficient for the mth peptide, m= 1, . . . ,Mp,
at microarray d˜, is computed as
rd˜,m =
D∑
d=1
(
fld,m − f¯lm
) (
bd˜,d − (1/D)
)
(
D∑
d=1
(
fld,m − f¯lm
)2)1/2( D∑
d=1
(
bd˜,d − (1/D)
)2)1/2 (A.8)
where fld,m is the fluorescent intensity of the mth peptide of the dth array,
f¯lm =
1
D
D∑
d=1
fld,m ,
is the fluorescence sample mean of the mth peptide across all D microarray datasets,
and bd˜,d is 1 if d˜= d and 0 otherwise,
One example of a monoclonal antibody for which a different peptide selection crite-
rion can give different estimation results is 2C11. For this monoclonal antibody, using
the fluorescent intensity peptide selection criterion demonstrates that the antibodies
bind weakly to the peptides relative to background binding and cannot be detected at
any threshold. In particular, there are many peptides with high fluorescent intensity
that do not bind to the 2C11 antibody. This is illustrated in Figure A.3(a), where
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Figure A.3: Histogram Plots for the Monoclonal Antibody 2C11 Using Values of (a)
Fluorescence and (b) Correlation. Top Plots Process All Peptide Sequences; Bottom
Plots Process Only Peptides with the Exact Epitope Sub-Sequence.
the figure on the top is a histogram of all of the 330k fluorescent intensity levels
on the array, while the figure on the bottom is a histogram of just the fluorescent
intensity levels of peptides which contain a sub-sequence of the 2C11 epitope. For
this dataset, as there are peptides with higher fluorescent intensities than most of the
peptides with the mAb epitope, the fluorescent intensity selection criterion fails to
provide correct epitope estimates. On the other hand, if the correlation value peptide
selection criterion is applied, an improved epitope estimation performance. This is
demonstrated in Figure A.3(b), where many of the peptides with the largest correla-
tion values are also the peptides which contain epitope sub-sequences. Note that an
epitope sub-sequence is four or more contiguous amino acids from the epitope and
that the fluorescent intensity levels in Figure A.3(a) were logarithmically transformed
to improve visualization.
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Thresholding. Depending on the peptide selection criterion, thresholding is
used to keep Ms  Mp peptide sequences as input to the epitope estimation. A
background fluorescent intensity threshold is used with the fluorescent intensity cri-
terion. With the correlation coefficient criterion, the correlation coefficient values
rd˜,m of the mth peptide, m= 1, . . . ,Mp, on the d˜ array in (A.8) are first ranked in
descending order and then compared to some threshold.
A.6.2 Epitope Estimation Algorigthms
The epitope candidate sequences are derived from the remaining Ppeptide array
sequences obtained after applying the selection method in Section A.6.1. There are
three different methods considered for epitope waveform parameter (EpiWP) estima-
tion, resulting in the detection and identification of the epitope candidate sequen-
ces. The epitope candidate sequences for the EpiWP-1 estimation method include
all possible sub-sequences of length L adopted from the peptide microarray sequen-
ces. The epitope candidate sequences for the EpiWP-2 estimation method include all
sub-sequences of length L from the peptide array sequences, together with the sub-
sequences formed by allowing for a single amino acid substitution (by any other type of
amino acid). The epitope candidate sequences for the EpiWP-3 estimation method
include all sub-sequences of length L from the peptide array sequences, together
with the sub-sequences formed by allowing for two adjacent amino acid substitutions.
Note that the allowable substitutions in EpiWP-2 and EpiWP-3 are only possible any
amino acid in a sub-sequence that is not at the amino-terminus or N-terminus (start
of an amino acid chain) or the C-terminus (end of amino acid chain).
The main steps of the estimation algorithm are summarized in Algorithm 13.
Using the down-selected Ms peptide sequences, the MPD is used to compare the
peptide sequences to Me epitope candidate sequences. The overall matching score
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uses the metric in (A.7) and the number of peptide sequences that include each of the
Me epitope candidate sequences. Algorithm 14 finds the maximum match between
two sequences with dissimilar lengths. The two sequences are peptide array sequence
of length N and the epitope candidate sequence of length L, where N > L. The
algorithm first maps both sequences to Gaussian waveforms and then uses the MPD
to perform the matching. The number of maximum matches found using Algorithm 13
is recorded, and epitope candidate sequences are sorted in descending order according
to the number of peptides they were found in. The epitope candidate sequences that
occur most frequently are the top epitope estimates.
Algorithm 13 Matches between Peptides and Epitope Candidate Sequences.
for i = 1 to Ms do
for j = 1 to Me do
Run Algorithm 14 on the ith peptide and jth epitope candidate sequences
Record the number of maximum matches for each epitope candidate sequence
end for
end for
Algorithm 14 Maximum Match between Two Sequences.
for n= 1 to N − L+ 1 do
Map peptide sequence p[m], m=n, . . . , n+ L− 1, onto TF waveforms gpept(t)
Map epitope candidate sequence e[l], l= 1, . . . , L, onto TF waveforms gepit(t)
Perform MPD using gpept(t) and gepit(t) to find score sepit
end for
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A.6.3 Evaluation of Epitope Estimation
In order to evaluate the performance of the random-sequence peptide microarray
with the EpiWP estimation method for identifying antibody epitopes, eight mono-
clonal antibodies (mAbs) were acquired. The mAbs used have known epitopes that
were used to probe the microarray. Monoclonal antibodies are used in the evaluation,
instead of blood samples from patients, as the mAbs bind to a single linear epitope
selected for high specificity for the antigen [44, 60-63]. On the contrary, epitopes for
most diseases are not known; even if the epitope for a single strain of a disease is
known, it may not be known for the specific strain of the analyzing sample. The
mAb random-sequence peptide microarray data were provided by CIM [56]; each mi-
croarray sample consists of 330,000 peptide sequences (330k chip). Although this is
a large number of sequences on the array, only a small percentage of the sequences
bind to different mAbs.
Table A.2 provides a list of the eight mAbs used to demonstrate epitope waveform
parameter estimation. The known epitope of each mAb is provided in the third
column of this table. The last column provides the estimated epitopes with varying
lengths. The EpiWP estimation method performed well for all but the monoclonal
antibody ab8 epitope. Based on this result, the mAb epitope estimation performance
is about 88% accurate.
For most of the monoclonal antibody samples, the EpiWP-1 estimation method
performs well in estimating the true epitope. Two examples of this are for estimating
the epitopes of mAbs 2C11 and ab1. The true epitope of the monoclonal antibody
2C11 is NAHYYVFFEEQE; using EpiWP-1 finds YVFFEEQE as the epitope. Similarly, the
epitope for the monoclonal antibody ab1 is RHSVV; EpiWP-1 estimates epitope RHSVV.
The top results for these two epitopes are shown in Figures A.4(a) and A.4(b). In
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Antibody Full Estimated
Epitope Epitope
2C11 NAHYYVFFEEQE YVFFEEQE
4C1 QAFDSH AFDSH
A10 EEDFRV EDFRV
Ab-1 RHSVV RHSVV
Ab-8 SDLWKL -
DMLA AALEKD ALEKD
FLAG DYKDDDDK KDGD
HA YPYDVPDYA YDAPE
Table A.2: Epitope Estimates for Eight Monoclonal Antibodies.
some of monoclonal antibodies, an obvious substitution but not the exact epitope
is found. This is demonstrated in Figures A.5(a) and A.5(b) for the monoclonal
antibody HA with true epitope YPYDVPDYA. The EpiWP-1 estimation method results
in candidate epitopes YDAPE and PYDAP. Allowing one amino acid substitutions as in
estimation method EpiWP-2, the candidate epitopes are -YDAP and YDAP-. One way
to interpret this is that the Y in YDAPE is not required for binding, nor is the final P
in PYDAP; while the Y in YDAPE is part of the true epitope, the second P in PYDAP is
not.
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Figure A.4: Top Epitope Estimates Using Estimation Method EpiWP-1 for Antibody
(a) 2C11 (True Epitope NAHYYVFFEEQE) and (b) ab1 (True Epitope RHSVV).
A.6.4 Comparison with Existing Epitope Identification Methods
Existing sequence alignment approaches [10, 21-26, 64] can potentially be used
for the epitope estimation problem, in order to find similarities between peptide and
epitope sequences. However, most of these approaches were optimized for very long
amino acid sequencers and not for short-length peptide sequences [65]. An approach
for finding a motif or pattern among the peptides is a direct sequence analysis ap-
proach that compares peptide sequences to epitope sequences based on their primary
structure. This was demonstrated in [65] using data obtained using phage display
technology; the scoring used for this approach is similarity between the sequences.
Other approaches use pattern graphs, combinatorics for motif finding, exhaustive
length and substitution analysis, and optimization methods to find motifs by maxi-
mizing scoring functions [66-74]. A most recent statistical based approach arranges
peptides in position specific scoring matrices and computes their mean value for each
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Figure A.5: Top Epitope Estimates for Antibody HA (True eEpitope YPYDVPDYA)
Using Estimation Method (a) EpiWP-1 and EpiWP-2.
position; a threshold value is then used to identify positions where the mean differs
significantly [75].
Directly applied to immunosignaturing, a method called GuiTope was presented
in [47] for mapping random-sequence peptides to protein sequences. The method is
based on using a scoring matrix and a local alignment approach that compares simi-
larity results using a score threshold. Using GuiTope, monoclonal antibody epitopes
were estimated with about 74% to 81% accuracy.
A.7 Efficient Implementation of Epitope Estimation
The aforementioned pathogen detection and identification methods need to be re-
peated tens to hundreds of thousands of times to scan through all necessary peptide
sequences when estimating a single epitope. Therefore, for this method to be useful, it
is very important to decrease the runtime of the epitope estimation algorithm. When
implemented, the algorithm spends most of its time computing the multiplication
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in Equation (A.5). The inner product computational step involves sample multipli-
cation and summation of all products. Reducing the number of multiplications can
drastically decrease the algorithm’s runtime, as discussed next.
Reducing Number of Multiplications. To increase code efficiency, the time
domain waveforms described in Section A.5.1 can be constructed by selecting relevant
parameters T , F , and σ2 so that the Gaussian waveforms are close together in TF
but are non-overlapping. While the Gaussian waveforms are theoretically non-zero
across all time, setting T = 3σ2 and fixing the time-bandwidth product to be T F = 1,
is sufficient for the accuracy required in this application. The resulting Gaussian
waveforms can also be sampled at Nyquist to minimize the number of samples needed
to uniquely represent each frequency shift.
Frequency Domain Implementation of Epitope Estimation. Even after
taking steps to reduce the number of time domain multiplications, it is still more
efficient to represent the waveforms in the frequency domain, where each waveform is
sampled once at the location of all the frequency shifts. Because the Gaussian wave-
forms in the dictionary are non-overlapping, each of the frequency domain samples
will either be a 1 or a 0.
Eliminating all Multiplications. For the EpiWP-1 estimation method, the
multiplications in Equation (A.5) can be eliminated simply by counting the number
of Gaussian waveforms, in each epitope amino acid and peptide amino acid waveform
pairs, that occur at the same TF location. When matched in the TF plane, a maxi-
mum matching score is obtained when all waveform pairs share the same TF support.
The frequency domain implementation can still be used as it uses the smallest number
of samples.
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A.8 Conclusions
This work presented advanced signal processing approaches to analyze immunosig-
nature biosequences. Immunosignaturing technology uses random sequence peptide
microarrays to assess health status by associating antibodies from a biological sam-
ple to immune responses. The immunosignature processing requires the detection
and identification of antibody epitopes from the microarray peptide sequences to
discriminate between pathogens and diagnose diseases. This is achieved by first map-
ping characteristics of peptide and epitope sequences to parameters of highly-localized
Gaussian waveforms in the time-frequency plane. After down-selecting the large num-
ber of sequences from a microarray, time-frequency based matching methods are used
to estimate epitope candidates corresponding to specific pathogens. The performance
of the novel epitope detection and identification method is demonstrated using eight
monoclonal antibodies. The candidate sequences that resulted in a stronger response
for one antibody over the others corresponded well with the actual epitope sequences
that generated the monoclonal antibodies.
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